Skip to main content

Scientific Publications

  1. Parray AM, Nadkarni S, Chaudhari V, Shrikhande SV, Bhandare MS. Pancreaticoduodenectomy in the Portal Annular Pancreas-Mesopancreas Triangle Approach (with Video). Ann Surg Oncol. 2023 Jul 4. doi: 10.1245/s10434-023-13782-z. Epub ahead of print. PMID: 37402974.
  2. Pandrowala S, Gupta V, Bhandare MS, Shrikhande SV. Pancreaticoduodenectomy in a Case with Celiac Axis Stenosis: A Surgical Challenge. J Gastrointest Cancer. 2023 Jun 10. Doi: 10.1007/s12029-023-00948-x. Epub ahead of print. PMID: 37300749.
  3. Chaudhari V, Ramaswamy A, Srinivas S, Agarwal A, Seshadri RA, Talwar V, Bhargava P, Goel S, Kayal S, Rebala P, Prajapati B, Parikh D, Kothari J, Ch RM, Kadamapuzha JM, Kapoor D, Chaudhary A, Goel V, Singh S, Ghosh J, Lavingia V, Gupta A, Sekar A, Misra S, Vishnoi JR, Soni S, Varshney VK, Bairwa S, Bhandare M, Shrikhande SV, Ostwal V. Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) – Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study. J Gastrointest Cancer. 2023 Jun 5. doi: 10.1007/s12029-023-00936-1. Online ahead of print.PMID: 37273074
  4. Al-Sukhun S, Masannat Y, Wegman-Ostrosky T, Shrikhande SV, Manirakiza A, Fadelu T, Rebbeck TR. Germline Testing Around the Globe: Challenges in Different Practice Settings. Am Soc Clin Oncol Educ Book. 2023 May; 43:e390522. Doi: 10.1200/EDBK_390522. PMID: 37220318.
  5. Chopde A, Gupta A, Chaudhari V, Parghane R, Basu S, Ostwal V, Ramaswamy A, Puranik A, Shrikhande SV, Bhandare MS. Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours. Langenbecks Arch Surg. 2023 May 22;408(1):204. doi: 10.1007/s00423-023-02943-z.PMID: 37212896
  6. Sundaram S, Chhanchure U, Patil P, Seth V, Mahajan A, Bal M, Kaushal RK, Ramadwar M, Prabhudesai N, Bhandare M, Shrikhande SV, Mehta S. Rapid on-site evaluation (ROSE) versus macroscopic on-site evaluation (MOSE) for endoscopic ultrasound-guided sampling of solid pancreatic lesions: a paired comparative analysis using newer-generation fine needle biopsy needles. Ann Gastroenterol. 2023 May-Jun;36(3):340-346. doi: 10.20524/aog.2023.0790. Epub 2023 Apr 4. PMID: 37144017.
  7. Parray AM, Chaudhari V, Shrikhande SV, Bhandare MS. A Sequential “Top-Down” and “Retro Mesenteric Caudo-cranial Superior Mesenteric Artery Approach” for Posteriorly Located Locally Advanced Pancreatic Head Cancers. J Gastrointest Cancer. 2023 Apr 18. doi: 10.1007/s12029-023-00938-z. PMID: 37072610
  8. Karadza E, Haney CM, Limen EF, Müller PC, Kowalewski KF, Sandini M, Wennberg E, Schmidt MW, Felinska EA, Lang F, Salg G, Kenngott HG, Rangelova E, Mieog S, Vissers F, Korrel M, Zwart M, Sauvanet A, Loos M, Mehrabi A, de Santibanes M, Shrikhande SV, Abu Hilal M, Besselink MG, Müller-Stich BP, Hackert T, Nickel F. Development of biotissue training models for anastomotic suturing in pancreatic surgery. HPB (Oxford). 2023 Feb 9:S1365-182X(23)00041-2. doi: 10.1016/j.hpb.2023.02.002.PMID: 36828741
  9. Bhargava P, Das S, Ostwal V, Srinivas S, Bhandare M, Chaudhari V, Bal M, Mantri A, Kapoor A, Shrikhande SV, Ramaswamy A. An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers. South Asian J Cancer. 2022 Mar 22;11(2):112-117. doi: 10.1055/s-0041-1733349. eCollection 2022 Apr. PMID: 36466971
  10. Bhargava P, Shrikhande SV. First-line immunotherapy: Hype rather than near reality in gastric cancer. Natl Med J India. 2022 Mar-Apr;35(2):98-99. doi: 10.25259/NMJI_645_21.PMID: 36461855 
  11. Jadhav AS, Deodhar KK, Ramadwar M, Bal M, Kumar R, Goel M, Saklani A, Shrikhande SV. An audit of frozen sections for suspected gastrointestinal malignancies in a tertiary referral hospital in India. Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):796-801. doi: 10.4103/ijpm.ijpm_370_21.PMID: 36308183
  12. Ramaswamy A, Bhargava P, Srinivas S, Kannan S, Bhandare M, Chaudhari V, Mantri A, Kapoor A, Das S, Booma N, Chaugule D, Shrikhande SV, Ostwal V. Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pair Analysis. J Gastrointest Cancer. 2022 Oct 15. doi: 10.1007/s12029-022-00867-3. PMID: 36242748
  13. Choudhury S, Agrawal A, Rangarajan V, Puranik A, Bal M, Chaudhari V, Bhandare M, Purandare N, Shah S, Ramaswamy A, Ostwal V, Shrikhande SV. Impact of FDG PET/CT Scan in Changing Management of Well-Differentiated Neuroendocrine Tumors with Ki67 Index Less Than or Equal to 5. Clin Nucl Med. 2022 Nov 1;47(11):e676-e681. doi: 10.1097/RLU.0000000000004365. Epub 2022 Aug 12. PMID: 36215398
  14. Kazi M, Vispute T, Shah P, Ramadwar M, Bhandare MS, Shrikhande SV, Chaudhari VA. Localized gastric mesothelioma with nodal metastasis-an exceptionally rare entity. Indian J Surg Oncol. 2022 Sep;13(3):612-615. doi: 10.1007/s13193-022-01497-8. Epub 2022 Apr 3. PMID: 36187519
  15. Parray AM, Chaudhari VA, Bhandare MS, Madhabananda K, Muduly DK, Sudhindran S, Mathews J, Pradeep R, Thammineedi SR, Amal K, Chaudhary D, Jitender R, Pandey D, Amar P, Penumadu P, Kalayarasan R, Elamurugan TP, Kantharia C, Pujari S, Ramesh H, Somashekhar SP, Fernandes A, Sexena R, Singh RK, Lattoo MR, Shah OJ, Jeswanth S, Roy M, Thambudorai R, Shrikhande SV. Impact of Covid-19 on gastrointestinal cancer surgery: A National Survey. Langenbecks Arch Surg. 2022 Sep 13:1-11. doi: 10.1007/s00423-022-02675-6..PMID: 36098808
  16. Ramaswamy A, Srinivas S, Chaudhari V, Bhargava P, Bhandare M, Shrikhande SV, Ostwal V. Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status.   2022 Mar 24;16:1367. doi: 10.3332/ecancer.2022.1367. eCollection 2022. PMID: 35685956 
  17. Gupta V, Bhandare MS, Chaudhari V, Parray A, Shrikhande SV. Organ preserving pancreatic resections offer better long-term conservation of pancreatic function at the expense of high perioperative major morbidity: a fair trade-off for benign or low malignant potential pancreatic neoplasms-a single-center experience. Langenbecks Arch Surg. 2022 Mar 17. doi: 10.1007/s00423-022-02491-y. PMID: 35298681
  18. Parray AM, Chaudhari VA, Shrikhande SV, Bhandare MS. Mitigation strategies for post-operative pancreatic fistula after pancreaticoduodenectomy in high-risk pancreas: an evidence-based algorithmic approach”-a narrative review. Chin Clin Oncol. 2022 Feb;11(1):6. doi: 10.21037/cco-22-6.PMID: 35255695 
  19. Bhandare MS, Parray A, Chaudhari VA, Shrikhande SV. Minimally invasive surgery for pancreatic cancer-are we there yet? -a narrative review. Chin Clin Oncol. 2022 Feb;11(1):3. doi: 10.21037/cco-21-131.PMID: 35255692 
  20. Alrawashdeh W, Kamarajah SK, Gujjuri RR, Cambridge WA, Shrikhande SV, Wei AC, Abu Hilal M, White SA, Pandanaboyana S. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers. HPB (Oxford). 2021 Dec 30:S1365-182X(21)01745-7. doi: 10.1016/j.hpb.2021.12.019. PMID: 35042673 
  21. Pergolini I, Schorn S, Goess R, Novotny AR, Ceyhan GO, Friess H; International Study Group for Pancreatic Surgery (ISGPS), Shrikhande SV, Demir IE. Drain use in pancreatic surgery: Results from an international survey among experts in the field. 2022 Jan 4:S0039-6060(21)01171-5. doi: 10.1016/j.surg.2021.11.023.PMID: 34996604
  22. Chaudhari VA, Mitra A, Gupta V, Ostwal V, Ramaswamy A, Engineer R, Sirohi B, Shetty N, Bal M, DeSouza A, Bhandare MS, Shrikhande SV. Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving evidence. 2021 Dec 15: S0039-6060(21)00978-8. doi: 10.1016/j.surg.2021.10.018. PMID: 34922745
  23. Nagakawa Y, Nakata K, Nishino H, Ohtsuka T, Ban D, Asbun HJ, Boggi U, He J, Kendrick ML, Palanivelu C, Liu R, Wang SE, Tang CN, Takaori K, Abu Hilal M, Goh BKP, Honda G, Jang JY, Kang CM, Kooby DA, Nakamura Y, Shrikhande SV, Wolfgang CL, Yiengpruksawan A, Yoon YS, Watanabe Y, Kozono S, Ciria R, Berardi G, Garbarino GM, Higuchi R, Ikenaga N, Ishikawa Y, Maekawa A, Murase Y, Zimmitti G, Kunzler F, Wang ZZ, Sakuma L, Takishita C, Osakabe H, Endo I, Tanaka M, Yamaue H, Tanabe M, Wakabayashi G, Tsuchida A, Nakamura M. International Expert Consensus on Precision Anatomy for Minimally Invasive Pancreatoduodenectomy: PAM-HBP Surgery Project.J Hepatobiliary Pancreat Sci. 2021 Nov 16. doi: 10.1002/jhbp.1081.PMID: 3478317
  24. Singh HK, Chaudhari V, Batra S, Ostwal V, Ramaswamy A, Mokal S, Shrikhande SV, Bhandare MS. Radical D2 gastrectomy with adjuvant chemotherapy for stage IB/II/III distal gastric cancers in the era of perioperative chemotherapy: A propensity matched comparison. Am J Surg. 2021 Oct 27: S0002-9610(21)00630-9. doi: 10.1016/j.amjsurg.2021.10.036. PMID: 34756584.
  25. Ban D, Nishino H, Ohtsuka T, Nagakawa Y, Abu Hilal M, Asbun HJ, Boggi U, Goh BKP, He J, Honda G, Jang JY, Kang CM, Kendrick ML, Kooby DA, Liu R, Nakamura Y, Nakata K, Palanivelu C, Shrikhande SV, Takaori K, Tang CN, Wang SE, Christopher WL, Yiengpruksawan A, Yoon YS, Ciria R, Berardi G, Garbarino GM, Higuchi R, Ikenaga N, Ishikawa Y, Kozono S, Maekawa A, Murase Y, Watanabe Y, Zimmitti G, Kunzler F, Wang ZZ, Sakuma L, Osakabe H, Takishita C, Endo I, Tanaka M, Yamaue H, Tanabe M, Wakabayashi G, Tsuchida A, Nakamura M. International Expert Consensus on Precision Anatomy for Minimally Invasive Distal Pancreatectomy: PAM-HBP Surgery Project. J Hepatobiliary Pancreat Sci. 2021 Oct 31. doi: 10.1002/jhbp.1071. PMID: 34719123
  26. COVIDSurg Collaborative, Shrikhande SV. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Oct 5: S1470-2045(21)00493-9. doi: 10.1016/S1470-2045(21)00493-9. PMID: 34624250
  27. Marchegiani G, Barreto SG, Bannone E, Sarr M, Vollmer CM, Connor S, Falconi M, Besselink MG, Salvia R, Wolfgang CL, Zyromski NJ, Yeo CJ, Adham M, Siriwardena AK, Takaori K, Hilal MA, Loos M, Probst P, Hackert T, Strobel O, Busch ORC, Lillemoe KD, Miao Y, Halloran CM, Werner J, Friess H, Izbicki JR, Bockhorn M, Vashist YK, Conlon K, Passas I, Gianotti L, Del Chiaro M, Schulick RD, Montorsi M, Oláh A, Fusai GK, Serrablo A, Zerbi A, Fingerhut A, Andersson R, Padbury R, Dervenis C, Neoptolemos JP, Bassi C, Büchler MW, Shrikhande SV; Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS). International Study Group for Pancreatic Surgery.Ann Surg. 2021 Sep 29. doi: 10.1097/SLA.0000000000005226. PMID: 34596077
  28. Mhatre S, Lacey B, Sherliker P, Chatterjee N, Rajaraman P, Goel M, Patkar S, Ostwal V, Patil P, Shrikhande SV, Chitkara G, Badwe R, Lewington S, Dikshit R. Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India. Int J Epidemiol. 2021 Sep 22: dyab197. doi: 10.1093/ije/dyab197. PMID: 34550362
  29. Shrikhande SV, Prasad VGM, Domínguez-Muñoz JE, Weigl KE, Sarda KD. In vitro Comparison of Pancreatic Enzyme Preparations Available in the Indian Market. Drug Des Devel Ther. 2021 Sep 7; 15:3835-3843. doi: 10.2147/DDDT.S319949. eCollection 2021.PMID: 34522087
  30. Gupta V, Chaudhari V, Shrikhande SV, Bhandare MS. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study. Gastrointest Cancer. 2021 Aug 18. doi: 10.1007/s12029-021-00683-1. PMID: 34406625J
  31. Pachaury A, Chaudhari V, Batra S, Ramaswamy A, Ostwal V, Engineer R, Bal M, Shrikhande SV, Bhandare MS. ASO Visual Abstract: Pathologic N3 Stage (pN3/ypN3) Gastric Cancer-Outcomes, Prognostic Factors, and Pattern of Recurrences after Curative Treatment. Ann Surg Oncol. 2021 Aug 9. doi: 10.1245/s10434-021-10480-6. PMID: 34370145
  32. Bhandare MS, Pachaury A, Chaudhari V, Shrikhande SV. ASO Authors Reflection: N3 Stage Gastric Cancer Needs Treatment Intensification. Ann Surg Oncol. 2021 Jul 25. doi: 10.1245/s10434-021-10510-3. PMID: 34308511
  33. Shrikhande SV, Verma M. A Prospective Observational Study to Determine Rate of Thromboprophylaxis in Oncology Patients Undergoing Abdominal or Pelvic Surgery. Indian J Surg Oncol. 2021 Jun;12(2):279-285. doi: 10.1007/s13193-021-01281-0. Epub 2021 Mar 1. PMID: 34290488.
  34. Pachaury A, Chaudhari V, Batra S, Ramaswamy A, Ostwal V, Engineer R, Bal M, Shrikhande SV, Bhandare MS. Pathological N3 Stage (pN3/ypN3) Gastric Cancer: Outcomes, Prognostic Factors and Pattern of Recurrences After Curative Treatment. Ann Surg Oncol. 2021 Jul 20. doi: 10.1245/s10434-021-10405-3 PMID: 34283313
  35. Gupta V, Bhandare M, Chaudhari V, Shrikhande S. Organ preserving pancreatic resections offers better long-term conservation of pancreatic function at the expense of significantly high perioperative major morbidity: A fair trade-off for benign or low malignant potential pancreatic neoplasms. Ann Hepatobiliary Pancreat Surg. 2021 Jun 30;25(Suppl 1): S369. doi: 10.14701/ahbps.EP-170.PMID: 34230433
  36. Probst P, Hüttner FJ, Meydan Ö, Abu Hilal M, Adham M, Barreto SG, Besselink MG, Busch OR, Bockhorn M, Del Chiaro M, Conlon K, Castillo CF, Friess H, Fusai GK, Gianotti L, Hackert T, Halloran C, Izbicki J, Kalkum E, Kelemen D, Kenngott HG, Kretschmer R, Landré V, Lillemoe KD, Miao Y, Marchegiani G, Mihaljevic A, Radenkovich D, Salvia R, Sandini M, Serrablo A, Shrikhande S, Shukla PJ, Siriwardena AK, Strobel O, Uzunoglu FG, Vollmer C, Weitz J, Wolfgang CL, Zerbi A, Bassi C, Dervenis C, Neoptolemos J, Büchler MW, Diener MK. Evidence Map of Pancreatic Surgery-A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2021 Jun 26: S0039-6060(21)00382-2. doi: 10.1016/j.surg.2021.04.023. PMID: 34187695
  37. Joshi R, Thomas M, Patkar S, Gupta AM, Panhale K, Rane PP, Ambulkar R, Goel M, Shrikhande SV, Agarwal V. Impact of enhanced recovery pathway in 408 gallbladder cancer resections. HPB (Oxford). 2021 Jun 7: S1365-182X (21)00161-1. doi: 10.1016/j.hpb.2021.05.010. PMID: 34187721
  38. Solanki SL, Pandrowala S, Nayak A, Bhandare M, Ambulkar RP, Shrikhande SV. Artificial intelligence in perioperative management of major gastrointestinal surgeries. World J Gastroenterol. 2021 Jun 7;27(21):2758-2770. doi: 10.3748/wjg.v27.i21.2758.PMID: 34135552
  39. Shinde R, Bhandare MS, Chaudhari V, Sarodaya V, Agarwal V, Shrikhande S. Preoperative Albumin-Globulin Ratio and Its Association with Perioperative and Long-Term Outcomes in Patients Undergoing Pancreatoduodenectomy. Dig Surg. 2021 May 26:1-8. doi: 10.1159/000516278. PMID: 34038911
  40. Bal M, Kathuria K, Yadav S, Shrikhande SV. Lymphangioma of Pancreas Masquerading as a Pancreatic Cystic Neoplasm. Indian J Surg Oncol. 2021 Apr;12(Suppl 1):221-223. doi: 10.1007/s13193-021-01295-8. Epub 2021 Mar 12. PMID: 33994750
  41. Schuh F, Mihaljevic AL, Probst P, Trudeau MT, Müller PC, Marchegiani G, Besselink MG, Uzunoglu F, Izbicki JR, Falconi M, Fernandez-Del Castillo C, Adham M, Z’graggen K, Friess H, Werner J, Weitz J, Strobel O, Hackert T, Radenkovic D, Kelemen D, Wolfgang C, Miao YI, Shrikhande SV, Lillemoe KD, Dervenis C, Bassi C, Neoptolemos JP, Diener MK, Vollmer CM Jr, Büchler MW. A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery (ISGPS). Ann Surg. 2021 Mar 12. doi: 10.1097/SLA.0000000000004855. PMID: 33914473
  42. Bhandare MS, Mondal A, Chaudhari V, Bal M, Yadav S, Ramaswamy A, Ostwal V, Shetty N, Shrikhande SV. Factors influencing local and distant recurrence following resection of periampullary cancer. Br J Surg. 2021 Mar 16: znaa143. doi: 10.1093/bjs/znaa143. PMID: 33723577.
  43. Sirohi B, Shrikhande SV, Gaikwad V, Patel A, Patkar S, Goel M, Bal M, Sharma A, Shrimali RK, Bhatia V, Kulkarni S, Srivastava DN, Kaur T, Dhaliwal RS, Rath GK; Indian Council of Medical Research Guidelines Working Group. Indian Council of Medical Research consensus document on hepatocellular carcinoma. Indian J Med Res. 2020 Nov;152(5):468-474. doi: 10.4103/ijmr.IJMR_404_20.
    PMID: 33707388.
  44. Collaborators, Stephen R Knight, Shrikhande SV, etc. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries. 2021 Jan 30;397(10272):387-397. doi: 10.1016/S0140-6736(21)00001-5. Epub 2021 Jan 21. PMID: 33485461. 
  45. Parghane RV, Bhandare M, Chaudhari V, Shrikhande SV, Ostwal V, Ramaswamy A, Talole S, Basu S. Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRTwith Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors. J Nucl Med. 2021 Feb 26: jnumed.120.258772. doi: 10.2967/jnumed.120.258772. PMID: 33637590.
  46. Pandrowala S, Parray A, Chaudhari V, Shrikhande SV, Bhandare MS. Portal Annular Pancreas (PAP): An Underestimated Devil in Pancreatic Surgery-Systematic Review of Literature and Case Report. J Gastrointest Surg.  2021 Feb 8. doi: 10.1007/s11605-021-04927-0. PMID: 33555524 
  47. Ban D, Garbarino GM, Ishikawa Y, Honda G, Jang JY, Kang CM, Maekawa A, Murase Y, Nagakawa Y, Nishino H, Ohtsuka T, Yiengpruksawan A, Endo I, Tsuchida A, Nakamura M; Study group of Precision Anatomy for Minimally Invasive Hepato-Biliary-Pancreatic surgery (PAM-HBP surgery). Collaborators Study group of Precision Anatomy for Minimally Invasive Hepato-Biliary-Pancreatic surgery (PAM-HBP surgery): Mohammed Abu Hilal, Horacio J Asbun, Ugo Boggi, Brian K P Goh, Jin He, Michael L Kendrick, David A Kooby, Rong Liu, Yoshiharu Nakamura, Kohei Nakata, Chinnusamy Palanivelu, Shailesh V Shrikhande, Kyoichi Takaori, Chung-Ngai Tang, Shin-E Wang, Christopher L Wolfgang, Yoo-Seok Yoon, Giammauro Berardi, Ryota Higuchi, Naoki Ikenaga, Shingo Kozono, Yusuke Watanabe, Giuseppe Zimmitti, Leon Sakuma, Masakazu Yamamoto. Surgical approaches for minimally invasive distal pancreatectomy: a systematic review. J Hepatobiliary Pancreat Sci. 2021 Feb 1. doi: 10.1002/jhbp. 902.. PMID: 33527758.
  48. Nakamura M, Wakabayashi G, Tsuchida A, Nagakawa Y; Study group of Precision Anatomy for Minimally Invasive Hepato-Biliary-Pancreatic surgery (PAM-HBP surgery). Collaborators Study group of Precision Anatomy for Minimally Invasive Hepato-Biliary-Pancreatic surgery (PAM-HBP surgery):  Yuta Abe, Mohammed Abu Hilal, Felipe Alconchel, Keiichi Akahoshi, Takeshi Aoki, Shunichi Ariizumi, Horacio J Asbun, Daisuke Ban, Andrea Benedetti Cacciaguerra, Giammauro Berardi, Ugo Boggi, Albert C Y Chan, Rawisak Chanwat, Kuo-Hsin Chen, Yajin Chen, Daniel Cherqui, Tan To Cheung, Ruben Ciria, Manuel Durán, Itaru Endo, David Fuks, Giovanni Maria Garbarino, Alain García Vázquez, David A Geller, Brian K P Goh, Nicolas Golse, Naoto Gotohda, Ho-Seong Han, Kiyoshi Hasegawa, Etsuro Hatano, Jin He, Ryota Higuchi, Goro Honda, Naoki Ikenaga, Yoshiya Ishikawa, Yukio Iwashita, Osamu Itano, Jin-Young Jang, Hironori Kaneko, Chang Moo Kang, Yutaro Kato, Michael L Kendrick, Ji Hoon Kim, David A Kooby, Shingo Kozono, Rong Liu, Santiago López-Ben, Aya Maekawa, Yoshihiro Miyasaka, Kazuteru Monden, Yasuhisa Mori, Mamoru Morimoto, Yoshiki Murase, Yoshiharu Nakamura, Kohei Nakata, Hitoe Nishino, Satoshi Ogiso, Takao Ohtsuka, Hiroaki Osakabe, Chinnusamy Palanivelu, Fernando Rotellar, Yoshihiro Sakamoto, Leon Sakuma, Chikara Shirata, Shailesh V Shrikhande,Atsushi Sugioka, Kyoichi Takaori, Chie Takishita, Minoru Tanabe, Chung-Ngai Tang, Federico Tomassini, Takeshi Urade, Taiga Wakabayashi, Shin-E Wang, Yusuke Watanabe, Christopher L Wolfgang, Masakazu Yamamoto, Anusak Yiengpruksawan, Yoo-Seok Yoon, Tomoharu Yoshizumi, Giuseppe Zimmitt. Precision anatomy for minimally invasive hepatobiliary pancreatic surgery: PAM-HBP Surgery Project. J Hepatobiliary Pancreat Sci. 2020 Dec 15. doi: 10.1002/jhbp.885. PMID: 33319505.
  49. Kazi M, Shrikhande SV, Chaudhari VA, Kurunkar S, Bhandare MS. Emergency Radical Gastrectomy with Pancreatico-duodenectomy for a Recent Onset Perforation of Locally Advanced Gastric Cancer with Pancreatic Head Involvement-Exceptional but a Definite Option.Indian J Surg Oncol. 2020 Sep;11(Suppl 2):278-281. doi: 10.1007/s13193-020-01189-1. Epub 2020 Aug 29. PMID: 33364719
  50. Puranik AD, Rangarajan V, Gosavi A, Shetty N, Gala K, Kulkarni S, Mohite A, Patkar S, Goel M, Shrikhande SV, Ramaswamy A, Ostwal V, Purandare NC, Agrawal A, Shah S. Prognostic value of imaging-based parameters in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial radioembolization. Nucl Med Commun. 2020 Dec 9. doi: 10.1097/MNM.00000000000
    01334. PMID: 33306631
  51. Balduzzi A, van der Heijde N, Alseidi A, Dokmak S, Kendrick ML, Polanco PM, Sandford DE, Shrikhande SV, Vollmer CM, Wang SE, Zeh HJ, Hilal MA, Asbun HJ, Besselink MG; Risk factors and outcomes of conversion in minimally invasive distal pancreatectomy: a systematic review. International Evidence-based Guidelines of Minimally Invasive Pancreas Resection Group. Langenbecks Arch Surg. 2020 Dec 10. doi: 10.1007/s00423-020-02043-2.PMID: 33301071
  52. Shrikhande SV. Invited commentary: Evolving landscape of postoperative hyperamylasemia, postoperative acute pancreatitis, and postoperative pancreatic fistula: Time for a unifying definition, Surgery. 2020 Nov 27: S0039-6060(20)30730-3. doi: 10.1016/j.surg.2020.10.024. PMID: 33257035 
  53. Kumar NA, Desouza A, Bhandare MS, Murugan JR, Khandelwal G, Chaudhari V, Ostwal V, Shrikhande SV. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach. Langenbecks Arch Surg. 2020 Nov 26. doi: 10.1007/s00423-020-02020-9 PMID: 33242137
  54. Shrikhande SV, Chaudhary A, Krishnamurthy A, Rao GV, Chaturvedi H, Kar M, Deo SVS, Chaudhari V, Somashekhar SP. Surgical Oncology Practice in the Wake of COVID-19 Crisis. Indian J Surg Oncol. 2020 Nov 7:1-7. doi: 10.1007/s13193-020-01240-1. PMID: 33191994
  55. Mhatre S, Richmond RC, Chatterjee N, Rajaraman P, Wang Z, Zhang H, Badwe R, Goel M, Patkar S, Shrikhande SV, Patil PS, Davey Smith G, Relton CL, Dikshit RP. The role of gallstones in gallbladder cancer in India: a Mendelian randomization study. Cancer Epidemiol Biomarkers Prev. 2020 Nov 13: cebp.0919.2020. doi: 10.1158/1055-9965.EPI-20-0919. PMID: 33187967
  56. Parray A, Bhandare MS, Pandrowala S, Chaudhari VA, Shrikhande SV. Peri-operative, long-term, and quality of life outcomes after pancreaticoduodenectomy in the elderly: greater justification for periampullary cancer compared to pancreatic head cancer. HPB (Oxford). 2020 Oct 8: S1365-182X(20)31161-8. doi: 10.1016/j.hpb.2020.09.016.
    PMID: 33041206
  57. Ostwal V, Basu S, Bhargava P, Shah M, Parghane RV, Srinivas S, Chaudhari V, Bhandare MS, Shrikhande SV, Ramaswamy A. Capecitabine-Temozolomide (CAPTEM) in advanced Grade 2 and grade 3 Neuroendocrine neoplasms (NENs) – benefits of chemotherapy in NENs with significant 18FDG uptake. 2020 Oct 5. doi: 10.1159/000511987. PMID: 33017827
  58. Basu S, Chakraborty S, Parghane RV, Kamaldeep, Ranade R, Thapa P, Asopa RV, Sonawane G, Nabar S, Shimpi H, Chandak A, Vimalnath KV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Shrikhande SV, Sirohi B, Dash A, Banerjee S. One decade of ‘Bench-to-Bedside’ peptide receptor radionuclide therapy with indigenous [ 177Lu] Lu-DOTATATE obtained through ‘Direct’ neutron activation route: lessons learnt including practice evolution in an Indian setting. Am J Nucl Med Mol Imaging. 2020 Aug 25;10(4):178-211. eCollection 2020.PMID: 32929396 
  59. Parghane RV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Talole S, Shrikhande SV, Basu S. Long-term outcome of “Sandwich” chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease. Eur J Nucl Med Mol Imaging. 2020 Sep 2. doi: 10.1007/s00259-020-05004-5. PMID: 32876706
  60. Nekkanti SS, Vasudevan Nair S, Parmar V, Saklani A, Shrikhande S, Sudhakar Shetty N, Joshi A, Murthy V, Patkar N, Khattry N, Gupta S. Mandatory preoperative COVID-19 testing for cancer Patients-Is it justified? J Surg Oncol. 2020 Aug 25. doi: 10.1002/jso.26187. PMID: 32841386 
  61. van der Heijde N, Balduzzi A, Alseidi A, Dokmak S, Polanco PM, Sandford D, Shrikhande SV, Vollmer C, Wang SE, Besselink MG, Asbun H, Abu Hilal M. The role of older age and obesity in minimally invasive and open pancreatic surgery: A systematic review and meta-analysis. International Evidence-based Guidelines of Minimally Invasive Pancreas Resection Group. 2020 Jul 14:S1424-3903(20)30211-8. doi: 10.1016/j.pan.2020.06.013. PMID: 32782197 
  62. Kulkarni RV, Patil V, Bhandare MS, Chaudhari VA, Shrikhande SV. Vein resection without reconstruction (VROR) in pancreatoduodenectomy: expanding the surgical spectrum for locally advanced pancreatic tumours. Langenbecks Arch Surg. 2020 Aug 10. doi: 10.1007/s00423-020-01954-4. PMID: 32776209
  63. Grupo Internacional de Estudos de Câncer Hepatopancreatobiliar – ISG-HPB-Cancer, Coimbra FJF, Torres OJM, Alikhanov R, Agarwal A, Pessaux P, Fernandes ESM, Quireze-Junior C, Araujo RLC, Godoy AL, Waechter FL, Resende AP, Boff MF, Coelho GR, Rezende MB, Linhares MM, Belotto M, Moraes-Junior JMA, Amaral PCG, Pinto RD, Genzini T, Lima AS, Ribeiro HSC, Ramos EJ, Anghinoni M, Pereira LL, Enne M, Sampaio A, Montagnini AL, Diniz A, Jesus VHF, Sirohi B, Shrikhande SV, Peixoto RDA, Kalil AN, Jarufe N, Smith M, Herman P. BRAZILIAN CONSENSUS ON INCIDENTAL GALLBLADDER CARCINOMA. Arq Bras Cir Dig. 2020 Jul 8;33(1):e1496. doi: 10.1590/0102 672020190001e1496.
    PMID: 32667526 
  64. Balakrishnan A, Lesurtel M, Siriwardena AK, Heinrich S, Serrablo A, Besselink MGH, Erkan M, Andersson B, Polak WG, Laurenzi A, Olde Damink SWM, Berrevoet F, Frigerio I, Ramia JM, Gallagher TK, Warner S, Shrikhande SV, Adam R, Smith MD, Conlon KC, Delivery of Hepato-Pancreato-Biliary Surgery During the COVID-19 Pandemic: An European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Cross-Sectional Survey. E-AHPBA Scientific and Research Committee. HPB (Oxford). 2020 Jun 10: S1365-182X (20)31040-6. doi: 10.1016/j.hpb.2020.05.012. PMID: 32565039.
  65. Shrikhande SV, Pai PS, Bhandare MS, Bakshi G, Chaukar DA, Chaturvedi P, Goel M, Gulia A, Qureshi SS, Maheshwari A, Moiyadi A, Nair S, Nair NS, Karimundackal G, Saklani AP, Shankhadhar VK, Parmar V, Divatia JV, Pramesh CS, Puri A, Badwe RA; Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care Policy, all collaborators from Department of Surgical Oncology. Ann Surg. 2020 Jun 8. doi: 10.1097/SLA.
    0000000000004116. PMID: 32520743
  66. Shinde RS, Naik MD, Shinde SR, Bhandare MS, Chaudhari VA, Shrikhande SV, Dcruz AK. To Do or Not to Do? -A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic. Version 2. Indian J Surg Oncol. 2020 May 11;11(2):1-7. doi: 10.1007/s13193-020-01086-7.PMID: 32395064.
  67. Shrikhande SV, Shinde RS, Chaudhari VA, Kurunkar SR, Desouza AL, Agarwal V, Bhandare MS. Correction to: Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Cancer Surgery Across India.  World J Surg. 2020 Apr 23. doi: 10.1007/s00268-020-05519-w. PMID: 32322940
  1. Shinde RS, Acharya R, Chaudhari VA, Bhandare MS, Mungroop TH, Klompmaker S, Besselink MG, Shrikhande SV. External validation and comparison of the original, alternative and updated-alternative fistula risk scores for the prediction of postoperative pancreatic fistula after pancreatoduodenectomy. Pancreatology. 2020 Apr 11. pii: S1424-3903(20)30135-6. doi: 10.1016/j.pan.2020.04.006. PMID:32340876
  2. Miao Y, Lu Z, Yeo CJ, Vollmer CM Jr, Fernandez-Del Castillo C, Ghaneh P, Halloran CM, Kleeff J, de Rooij T, Werner J, Falconi M, Friess H, Zeh HJ, Izbicki JR, He J, Laukkarinen J, Dejong CH, Lillemoe KD, Conlon K, Takaori K, Gianotti L, Besselink MG, Del Chiaro M, Montorsi M, Tanaka M, Bockhorn M, Adham M, Oláh A, Salvia R, Shrikhande SV, Hackert T, Shimosegawa T, Zureikat AH, Ceyhan GO, Peng Y, Wang G, Huang X, Dervenis C, Bassi C, Neoptolemos JP, Büchler MW; Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2020 Apr 2. pii: S0039-6060(20)30103-3. doi: 10.1016/j.surg.2020.02.018. PMID:32249092
  3. Siriwardena AK, Windsor J, Zyromski N, Marchegiani G, Radenkovic D, Morgan C, Passas I, Olah A, Conlon KC, Smith M, Busch O, Baltatzis M, Besselink MG, Vollmer C, Castillo CF, Friess H, Garcea G, Burmeister S, Hackert T, Lillemoe KD, Schulick R, Shrikhande SV, Smith A, Gianotti L, Falconi M, Adams D, Adham M, Andersson R, Del Chiaro M, Devar J, Jegatheeswaran S, van Santvoort H, Khatkov I, Izbicki J, Büchler M, Neoptolemos JP, Bassi C, Dervenis C. Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS). Surgery. 2020 Mar 14. pii: S0039-6060(20)30073-8. doi: 10.1016/j.surg.2020.02.007. PMID: 32183994.
  4. Shinde RS, Pandrowala S, Navalgund S, Pai E, Bhandare MS, Chaudhari VA, Sullivan R, Shrikhande SV. Centralisation of Pancreatoduodenectomy in India: Where Do We Stand? World J Surg. 2020 Mar 11. doi: 10.1007/s00268-020-05466-6. Review. PMID:32161986
  5. Amnekar RV, Khan SA, Rashid M, Khade B, Thorat R, Gera P, Shrikhande SV, Smoot DT, Ashktorab H, Gupta S. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer. World J Gastroenterol. 2020 Feb 14;26(6):598-613. doi: 10.3748/wjg. v26.i6.598. PMID:32103870.
  6. Shrikhande SV, Shinde RS, Chaudhari VA, Kurunkar SR, Desouza AL, Agarwal V, Bhandare MS. Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Cancer Surgery Across India. World J Surg. 2019 Oct 22. doi: 10.1007/s00268-019-05235-0.PMID:31641837
  7. Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D’Angelica MI, Balduzzi A, Bassi C, Björnsson B, Boggi U, Callery MP, Del Chiaro M, Coimbra FJ, Conrad C, Cook A, Coppola A, Dervenis C, Dokmak S, Edil BH, Edwin B, Giulianotti PC, Han HS, Hansen PD, van der Heijde N, van Hilst J, Hester CA, Hogg ME, Jarufe N, Jeyarajah DR, Keck T, Kim SC, Khatkov IE, Kokudo N, Kooby DA, Korrel M, de Leon FJ, Lluis N, Lof S, Machado MA, Demartines N, Martinie JB, Merchant NB, Molenaar IQ, Moravek C, Mou YP, Nakamura M, Nealon WH, Palanivelu C, Pessaux P, Pitt HA, Polanco PM, Primrose JN, Rawashdeh A, Sanford DE, Senthilnathan P, Shrikhande SV, Stauffer JA, Takaori K, Talamonti MS, Tang CN, Vollmer CM, Wakabayashi G, Walsh RM, Wang SE, Zinner MJ, Wolfgang CL, Zureikat AH, Zwart MJ, Conlon KC, Kendrick ML, Zeh HJ, Hilal MA, Besselink MG; The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection. International Study Group on Minimally Invasive Pancreas Surgery (I-MIPS). Ann Surg. 2019 Sep 16. doi: 10.1097/SLA.
    0000000000003590. PMID: 31567509
  8. Chaudhari VA, Pradeep R, Ramesh H, Bhandare MS, Dhar P, Pal S, Palaniswamy S, Jeswanth S, Menon RN, Singh AN, Sabnis S, Rao GV, Shrikhande SV. Surgery for cystic tumors of pancreas: Report of high-volume, multicenter Indian experience over a decade. Surgery. Sep 19. pii: S0039-6060(19)30476-3. doi: 10.1016/j.surg.2019.07.013. PMID: 31543321
  9. Harris C, Ostwal V, Vallathol DH, Dusane R, Mandavkar S, Patkar S, Ramaswamy A, Shrikhande SV. Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers. South Asian J Cancer. 2019 Jul-Sep;8(3):166-167. doi: 10.4103/sajc.sajc_182_18. PMID:31489289
  10. Zaidi MY, Abou-Alfa GK, Ethun CG, Shrikhande SV, Goel M, Nervi B, Primrose J, Valle JW, Maithel SK. Evaluation and management of incidental gallbladder cancer. Chin Clin Oncol. 2019 Aug;8(4):37. doi: 10.21037/cco.2019.07.01. Epub 2019 Aug 5. PMID:31431030
  11. Ramaswamy A, Bhandare M, Bal M, Shrirangwar S, Kataria P, Majumdar S, Swami R, Rohila J, Chaudhari V, Mandavkar S, Chavan N, Shrikhande SV, Ostwal V. Clinico-pathological correlates and survival outcomes in 214 resected ampullary adenocarcinomas – are outcomes different in intestinal and pancreatobiliary subtypes with adjuvant gemcitabine? HPB (Oxford). 2019 Aug 9. pii: S1365-182X(19)30620-3. doi: 10.1016/j.hpb.2019.07.006. PMID: 31405778
  12. Shinde RS, Bhandare M, Chaudhari V, Shrikhande SV. Cutting-edge strategies for borderline resectable pancreatic cancer. Ann Gastroenterol Surg. 2019 Apr 25;3(4):368-372. doi: 10.1002/ags3.12254. eCollection 2019 Jul. Review. PMID: 31346575
  13. Lewis S, Sastri SC, Arya S, Mehta S, Patil P, Shrivastava S, Phurailatpam R, Shrikhande SV, Engineer R. Dose escalated concurrent chemo-radiation in borderline resectable and locally advanced pancreatic cancers with tomotherapy based intensity modulated radiotherapy: a phase II study. J Gastrointest Oncol. 2019 Jun;10(3):474-482. doi: 10.21037/jgo.2019.01.25. PMID:31183197
  1. Sivasanker M, Desouza A, Bhandare M, Chaudhari V, Goel M, Shrikhande SV. Radical antegrade modular pancreatosplenectomy for all pancreatic body and tail tumors: rationale and results. Langenbecks Arch Surg. 2019 Feb 21. doi: 10.1007/s00423-019-01763-PMID:30790046
  2. Ramaswamy A, Ostwal V, Goel A, Bhargava P, Srinivas S, Dsouza S, Shrikhande SV. Treatment practices for metastatic pancreatic cancer: Can we deliver an appropriately efficacious and safe regimen in Indian patients? Indian J Cancer. 2018 Apr-Jun;55(2):138-143. doi: 10.4103/ijc.IJC_552_17. PMID:30604724
  3. Ghose J, Bhamre R, Mehta N, Desouza A, Patkar S, Dhareshwar J, Goel M, Shrikhande SV. Resection of the Inferior Vena Cava for Retroperitoneal Sarcoma: Six Cases and a Review of Literature. Indian J Surg Oncol. 2018 Dec;9(4):538-546. doi: 10.1007/s13193-018-0796-9. Epub 2018 Jul 19. PMID:30538385
  4. Ostwal V, Sahu A, Zanwar S, Nayak L, Shrikhande SV, Shetty N, Gupta S, Ramaswamy A. Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre. Indian J Med Res. 2018 Sep;148(3):284-290. doi: 10.4103/ijmr.IJMR_249_17. PMID: 30425218
  5. Chaudhari IA, Khobragade K, Bhandare M, Shrikhande SV. Management of fibrolamellar hepatocellular carcinoma. Chin Clin Oncol. 2018 Oct;7(5):51. doi: 10.21037/cco.2018.08.08. PMID: 30395718
  6. Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A. ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in Early Stage Gallbladder Cancer. Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31916. PMID:30304546
  7. Nagakawa Y, Nakamura Y, Honda G, Gotoh Y, Ohtsuka T, Ban D, Nakata K, Sahara Y, Velasquez VVD, Takaori K, Misawa T, Kuroki T, Kawai M, Morikawa T, Yamaue H, Tanabe M, Mou Y, Lee WJ, Shrikhande SV, Conrad C, Han HS, Tang CN, Palanivelu C, Kooby DA, Asbun HJ, Wakabayashi G, Tsuchida A, Takada T, Yamamoto M, Nakamura M. Learning curve and surgical factors influencing the surgical outcomes during the initial experience with laparoscopic pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2018 Oct 6. doi: 10.1002/jhbp.586. PMID:30291768
  8. Ratnayake CB, Loveday BP, Shrikhande SV, Windsor JA, Pandanaboyana S. Impact of preoperative sarcopenia on postoperative outcomes following pancreatic resection: A systematic review and meta-analysis. Pancreatology. 2018 Sep 27. pii: S1424-3903(18)30688-4. doi: 10.1016/j.pan.2018.09.011. PMID: 30287167
  9. Bal M, Rane S, Talole S, Ramadwar M, Deodhar K, Patil P, Goel M, Shrikhande SV. Correction to: Tumour origin and R1 rates in pancreatic resections: towards consilience in pathology reporting. Virchows Arch. 2018 Oct 4. doi: 10.1007/s00428-018-2465-3. PMID:30284030
  10. Sikdar N, Saha G, Dutta A, Ghosh S, Shrikhande SV, Banerjee S. Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview. Curr Genomics, 2018 Sep;19(6):444-463. doi: 10.2174/
    1389202919666180221160753.     PMID:30258276
  11. Basavaiah G, Rent PD, Rent EG, Sullivan R, Towne M, Bak M, Sirohi B, Goel M, Shrikhande SV. Financial Impact of Complex Cancer Surgery in India: A Study of Pancreatic Cancer. J Glob Oncol. 2018 Sep;(4):1-9. doi: 10.1200/JGO.17.00151.
    PMID:30241272
  12. Kumar NAN, Bhandare MS, Chaudhari V, Sasi SP, Shrikhande SV. Analysis of 50 cases of solid pseudopapillary tumor of pancreas: Aggressive surgical resection provides excellent outcomes. Eur J Surg Oncol. 2018 Sep 8. pii: S0748-7983(18)31303-9. doi: 10.1016/j.ejso.2018.08.027. PMID: 30228023
  13. Ostwal V, Bose S, Sirohi B, Poladia B, Sahu A, Bhargava P, Doshi V, Dusane R, Nashikkar C, Shrikhande SV, Ramaswamy A. Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer. Indian J Cancer. 2018 Jan-Mar;55(1):88-93. doi: 10.4103/ijc.IJC_353_17. PMID:30147101
  14. Ohtsuka T, Ban D, Nakamura Y, Nagakawa Y, Tanabe M, Gotoh Y, Velasquez VVD, Nakata K, Sahara Y, Takaori K, Honda G, Misawa T, Kawai M, Yamaue H, Morikawa T, Kuroki T, Mou Y, Lee WJ, Shrikhande SV, Tang CN, Conrad C, Han HS, Palanivelu C, Asbun HJ, Kooby DA, Wakabayashi G, Takada T, Yamamoto M, Nakamura M. Difficulty scoring system in laparoscopic distal pancreatectomy. J Hepatobiliary Pancreat Sci. 2018 Aug 17. doi: 10.1002/jhbp.578. PMID: 30118575
  15. Sirohi B, Chalkidou K, Pramesh CS, Anderson BO, Loeher P, El Dewachi O, Shamieh O, Shrikhande SV, Venkataramanan R, Parham G, Mwanahamuntu M, Eden T, Tsunoda A, Purushotham A, Stanway S, Rath GK, Sullivan R. Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. Lancet Oncol. 2018 Aug;19(8): e395-e406. doi: 10.1016/S1470-2045(18)30342-5. Review. PMID: 30102234
  16. Künzli BM, Spohnholz J, Braumann C, Shrikhande SV, Uhl W. Clinical Impact of Iatrogenic Small Bowel Perforation Secondary to Laparoscopic Cholecystectomy: A Single-center Experience.Surg Laparosc Endosc Percutan Tech. 2018 Jul 31. doi: 10.1097/SLE.0000000000000561. PMID:30067585
  17. Gianotti L, Besselink MG, Sandini M, Hackert T, Conlon K, Gerritsen A, Griffin O, Fingerhut A, Probst P, Hilal MA, Marchegiani G, Nappo G, Zerbi A, Amodio A, Perinel J, Adham M, Raimondo M, Asbun HJ, Sato A, Takaori K, Shrikhande SV, Chiaro MD, Bockhorn M, Izbicki JR, Dervenis C, Charnley RM, Martignoni ME, Friess H, de Pretis N, Radenkovic D, Montorsi M, Sarr MG, Vollmer CM, Frulloni L, Büchler MW, Bassi C. Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2018 Jul 17. pii: S0039-6060(18)30293-9. doi: 10.1016/j.surg.2018.05.040. PMID:30029989
  18. Raymond E, Kulke M, Qin SK, Yu X, Schenker M, Cubillo A, Lou W, Tomasek J, Thiis-Evensen E, Xu JM, Croitoru A, Khasraw M, Sedlackova E, Borbath I, Ruff P, Oberstein P, Ito T, Jia L, Hammel P, Shen L, Shrikhande SV, Shen Y, Sufliarsky J, Khan G, Morizane C, Galdy S, Khosravan R, Fernandez K, Rosbrook B, Fazio N. Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2018 Jul 10. doi: 10.1159/000491999. PMID:29991024
  19. Nakata K, Shikata S, Ohtsuka T, Ukai T, Miyasaka Y, Mori Y, Velasquez VVDM, Gotoh Y, Ban D, Nakamura Y, Nagakawa Y, Tanabe M, Sahara Y, Takaori K, Honda G, Misawa T, Kawai M, Yamaue H, Morikawa T, Kuroki T, Mou Y, Lee WJ, Shrikhande SV, Tang CN, Conrad C, Han HS, Chinnusamy P, Asbun HJ, Kooby DA, Wakabayashi G, Takada T, Yamamoto M, Nakamura M. Minimally invasive spleen preservation versus splenectomy during distal pancreatectomy: A systematic review and meta-analysis. J Hepatobiliary Pancreat Sci. 2018 Jun 26. doi: 10.1002/jhbp.569. PMID: 29943909
  20. Ramaswamy A, Jandyal S, Ostwal V, Engineer R, Lewis S, Bose S, Pande N, Shrikhande SV. Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon. Indian J Cancer. 2017 Jul-Sep;54(3):530-534. doi: 10.4103/ijc.IJC_377_17. PMID: 29798952.
  21. Bhandare MS, Mehta N, Chaudhari V, Kumar NA, Pai E, Goel M, Shrikhande SV. Re-Operative Pancreaticoduodenectomy: Challenges and Outcomes. Dig Surg. 2018 May 23:1-7. doi: 10.1159/000489275. PMID: 29791900
  22. Agarwal V, Thomas MJ, Joshi R, Chaudhari V, Bhandare M, Mitra A, deSouza A, Ambulkar R, Shrikhande SV. Improved Outcomes in 394 Pancreatic Cancer Resections: The Impact of Enhanced Recovery Pathway. J Gastrointest Surg. 2018 May 18. doi: 10.1007/s11605-018-3809-7. PMID:29777454.
  23. Barreto SG, Dutt A, Sirohi B, Shrikhande SV. Gallbladder cancer: a journey of a thousand steps. Future Oncol. 2018 May 3. doi: 10.2217/fon-2017-0576. PMID:29722272
  24. Chaudhari VA, Ostwal V, Patkar S, Sahu A, Toshniwal A, Ramaswamy A, Shetty NS, Shrikhande SV, Goel M. Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications.HPB (Oxford). 2018 Apr 26. pii: S1365-182X (18)30783-4. doi: 10.1016/j.hpb.2018.03.008.
  25. Ironside N, Barreto SG, Loveday B, Shrikhande SV, Windsor JA, Pandanaboyana Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg. 2018 May;105(6):628-636. doi: 10.1002/bjs.10832. Review. PMID: 29652079
  26. Palepu J, Shrikhande SV, Bhaduri D, Shah RC, Sirohi B, Chhabra V, Dhar P, Sastry R, Sikora S. Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry. Indian J Gastroenterol. 2018 Feb 19. doi: 10.1007/s12664-017-0808-7. PMID: 29457213.
  27. Palanivelu C, Kyoichi T, Mohammad AH, David AK, Go W, Agarwal A, Berti S, Marc B, Kuo Hsin C, Gumbs AA, Ho-Seong H, Goro H, Min Zheng H, Khatkov I, Hong Jin K, Li JT, Tran Cong DL, Machado MA, Akira M, Menon K, Nakamura M, Nagakawa Y, Juan P, Poves I, Shaheed SR, Liu R, Sa Cunha A, Palanisamy S, Shrikhande S, Gurumurthy SS, Sup Yoon D, Yoon YS. International Summit on Laparoscopic Pancreatic Resection (ISLPR) “Coimbatore Summit Statements”. Surg Oncol. 2017 Dec 27. pii: S0960-7404(17)30282-7. doi: 10.1016/j.suronc.2017.12.001.
  28. Mitra A, Pai E, Dusane R, Ranganathan P, DeSouza A, Goel M, Shrikhande SV. Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors. Langenbecks Arch Surg. 2018 Jan 23. doi: 10.1007/s00423-018-1653-6. PMID:29362882
  29. Torres OJM, Costa RCNDC, Costa FFM, Neiva RF, Suleiman TS, Souza YLMS, Shrikhande SV. Modified Heidelberg Technique for Pancreatic Anastomosis. Arq Bras Cir Dig. 2017 Oct-Dec;30(4):260-263.doi:10.1590/0102-6720201700040008.English,Portuguese.
    PMID:29340550
  30. van Rijssen LB, Gerritsen A, Henselmans I, Sprangers MA, Jacobs M, Bassi C, Busch OR, Fernández-Del Castillo C, Fong ZV, He J, Jang JY, Javed AA, Kim SW, Maggino L, Mitra A, Ostwal V, Pellegrini S, Shrikhande SV, Wilmink JW, Wolfgang CL, van Laarhoven HW, Besselink MG; COPRAC study group. Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers. Ann Surg. 2017 Dec 19. doi: 10.1097/SLA.0000000000002633. PMID:29261524.
  31. Basu S, Parghane RV, Ostwal V, Shrikhande SV. Neoadjuvant strategies for advanced pancreatic neuroendocrine tumors: should combined chemotherapy and peptide receptor radionuclide therapy be the preferred regimen for maximizing outcome? Nucl Med Commun. 2018 Jan;39(1):94-95. doi: 10.1097/MNM.0000000000000776. No abstract available. PMID:29206780
  32. Bhandare MS, Patkar S, Shetty N, Polnaya A, Kulkarni S, Dusane RR, Shrikhande SV, Goel M. Liver resection for HCC outside the BCLC criteria. Langenbecks Arch Surg. 2017 Dec 4. doi: 10.1007/s00423-017-1640-3. [Epub ahead of print] PMID:29199380
  33. Patkar S, Ostwal V, Ramaswamy A, Engineer R, Chopra S, Shetty N, Dusane R, Shrikhande SV, Goel M. Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center. J Surg Oncol. 2017 Sep 20. doi: 10.1002/ jso.24837. PMID: 28940502
  34. Kulkarni S, Shetty NS, Polnaya AM, Patil S, Gala K, Chivate R, Ostwal V, Ramaswamy A, Shrikhande SV, Goel M, Patkar S, Bhandare M, Rangarajan V, Nilendu P. Early outcomes of radiofrequency ablation in unresectable metastatic colorectal cancer from a tertiary cancer hospital in India. Indian J Radiol Imaging. 2017 Apr-Jun;27(2):200-206. doi: 10.4103/ijri.IJRI_24_17. PMID: 28744081
  35. Gaikwad V, Patkar S, Barreto SG, Sirohi B, Goel M, Shrikhande SV. Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: A Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a Distinct Entity. Indian J Surg. 2017 Jun;79(3):226-233. doi: 10.1007/s12262-016-1453-6. Epub 2016 Feb 13. PMID:28659676
  36. Mitra A, Shrikhande SV, Sirohi B. Histopathological regression after taxane based neoadjuvant chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma. Transl Gastroenterol Hepatol. 2017 May 16; 2:46. doi: 10.21037/tgh.2017.05.01. eCollection 2017.PMID: 28616602
  37. Joshi R, Thomas MJ, Bansode R, Mitra A, Chaudhari V, Desouza A, Singh V, Ambulkar R, Goel M,Shrikhande S, Agarwal V. Hepatic resections and enhanced recovery pathway: An Indian encounter. Clin Nutr ESPEN. 2016 Apr;12: e54. doi: 10.1016/j.clnesp.2016.02.078. Epub 2016 Apr 1. No abstract available. PMID:28531742
  38. Müssle B, Distler M, Wolk S,Shrikhande SV, Aust DE, Arlt A, Weitz J, Hackert T, Welsch T. Management of patients with pancreatic cystic lesions: A case-based survey. Pancreatology. 2017 Apr 10. pii: S1424-3903(17)30070-4. doi: 10.1016/j.pan.2017.04.004. PMID: 28456590
  39. Keditsu KK, Patkar S, Bal M,Shrikhande SV, Goel M. Gastrointestinal Neuroectodermal Tumor: a Diagnostic Dilemma. Indian J Surg. 2017 Apr;79(2):166-168. doi: 10.1007/s12262-016-1499-5. Epub 2016 May 7. PMID: 28442847
  40. Chaudhary D, Patkar S,Shrikhande SV, Goel M. Metastasis from Hepatocellular Carcinoma Masquerading as a Jugular Paraganglioma. J Gastrointest Cancer. 2017 Apr 4. doi: 10.1007/s12029-017-9943-8. PMID: 28374273
  41. Ostwal V, Sahu A, Ramaswamy A, Sirohi B, Bose S, Talreja V, Goel M, Patkar S, Desouza A,Shrikhande SV. Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis.J Gastric Cancer. 2017 Mar;17(1):21-32. doi: 10.5230/jgc.2017.17. e3. Epub 2017 Mar 16. PMID:28337360
  42. Kendrick ML1,van Hilst J2, Boggi U3, de Rooij T2, Walsh RM4, Zeh HJ5, Hughes SJ6, Nakamura Y7, Vollmer CM8, Kooby DA9, Asbun HJ10; Minimally Invasive Pancreatic Resection Organizing Committee. Collaborators (16) Asbun HJ11, Barkun J12, Besselink MG13, Boggi U3, Conlon KC14, Han HS15, Hansen PD16, Kendrick ML17, Kooby DA9, Montagnini AL18, Palanivelu C19, Røsok BI20, Shrikhande SV21, Wakabayashi G22, Zeh H5, Vollmer CM23. Minimally invasive pancreatoduodenectomy. HPB (Oxford). 2017 Mar;19(3):215-224. doi: 10.1016/j.hpb.2017.01.023. PMID:28317658
  43. Montagnini AL, Røsok BI, Asbun HJ, Barkun J, Besselink MG, Boggi U, Conlon KC, Fingerhut A, Han HS, Hansen PD, Hogg ME, Kendrick ML, Palanivelu C,Shrikhande SV, Wakabayashi G, Zeh H, Vollmer CM, Kooby DA. Standardizing terminology for minimally invasive pancreatic resection. HPB (Oxford). 2017 Mar;19(3):182-189. doi: 10.1016/j.hpb.2017.01.006. PMID: 28317657
  44. Hogg ME1,Besselink MG2, Clavien PA3, Fingerhut A4, Jeyarajah DR5, Kooby DA6, Moser AJ7, Pitt HA8, Varban OA9, Vollmer CM10, Zeh HJ 3rd11, Hansen P12; Minimally Invasive Pancreatic Resection Organizing Committee. Collaborators (16) Asbun HJ13, Barkun J14, Kendrick ML15, Kooby DA16, Hansen PD17, Vollmer CM10, Zeh H18, Montagnini AL19, Besselink MG20, Boggi U21, Conlon KC22, Røsok BI23, Han HS24, Palanivelu C25, Shrikhande SV26, Wakabayashi G27. Training in Minimally Invasive Pancreatic Resections: a paradigm shifts away from “See one, do one, Teach one“. HPB (Oxford). 2017 Feb 9. pii: S1365-182X (17)30050-3. doi: 10.1016/j.hpb.2017.01.016. PMID: 28190709
  45. Barkun J1, Fisher W2, Davidson G3, Wakabayashi G4, Besselink M5, Pitt H6, Holt J7, Strasberg S8, Vollmer C9, Kooby D10; Minimally Invasive Pancreatic Resection Organizing Committee. Collaborators (16) Asbun HJ11, Barkun J12, Besselink MG5, Boggi U13, Conlon KC14, Han HS15, Hansen PD16, Kendrick ML17, Kooby DA18, Montagnini AL19, Palanivelu C20, Røsok BI21, Shrikhande SV22, Wakabayashi G4, Zeh H23, Vollmer CM24. Research considerations in the evaluation of minimally invasive pancreatic resection (MIPR). HPB (Oxford). 2017 Mar 5. pii: S1365-182X (17)30035-7. doi: 10.1016/j.hpb.2017.01.005. Review PMID: 28274661
  46. Conlon KC1,de Rooij T2, van Hilst J2, Abu Hidal M3, Fleshman J4, Talamonti M5, Vanounou T6, Garfinkle R6, Velanovich V7, Kooby D8, Vollmer CM9; Minimally Invasive Pancreatic Resection Organizing Committee. Collaborators (16) Asbun HJ10, Barkun J11, Besselink MG12, Boggi U13, Conlon KC14, Han HS15, Hansen PD16, Kendrick ML17, Kooby DA18, Montagnini AL19, Palanivelu C20, Røsok BI21, Shrikhande SV22, Wakabayashi G23, Zeh H24, Vollmer CM25 . Minimally invasive pancreatic resections: cost and value perspectives. HPB (Oxford). 2017 Mar 4. pii: S1365-182X (17)30055-2. doi: 10.1016/j.hpb.2017.01.019. PMID: 28268161
  47. van Hilst J, de Rooij T, Abu Hilal M, Asbun HJ, Barkun J, Boggi U, Busch OR, Conlon KC, Dijkgraaf MG, Han HS, Hansen PD, Kendrick ML, Montagnini AL, Palanivelu C, Røsok BI, Shrikhande SV, Wakabayashi G, Zeh HJ, Vollmer CM, Kooby DA, Besselink MG. Worldwide survey on opinions and use of minimally invasive pancreatic resection. HPB (Oxford). 2017 Feb 16. pii: S1365-182X (17)30041-2. doi: 10.1016/j.hpb.2017.01.011. PMID:28215904
  48. Røsok BI, de Rooij T, van Hilst J, Diener MK, Allen PJ, Vollmer CM, Kooby DA,Shrikhande SV; Minimally invasive distal pancreatectomy. HPB (Oxford). 2017 Feb 16. pii: S1365-182X (17)30039-4. doi: 10.1016/j.hpb.2017.01.009. PMID:28215903
  49. Vollmer CM, Asbun HJ, Barkun J, Besselink MG, Boggi U, Conlon KC, Han HS, Hansen PD, Kendrick ML, Montagnini AL, Palanivelu C, Røsok BI,Shrikhande SV, Wakabayashi G, Zeh HJ, Kooby DA. Proceedings of the first international state-of-the-art conference on minimally-invasive pancreatic resection (MIPR). HPB (Oxford). 2017 Feb 8. pii: S1365-182X(17)30045-X. doi: 10.1016/j.hpb.2017.01.015. PMID: 28189345
  50. Sirohi B, Ostwal V, Dawood S, Lopes G, Talole S, Nashikkar C,Shrikhande S. Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules.Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):271-277. doi: 10.4103/0975851.195745. PMID28144095
  1. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adam M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R,Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2016 Dec 28. pii: S0039-6060(16)30757-7. doi: 10.1016/j.surg.2016.11.014. [Epub ahead of print] Review. PMID:28040257
  2. Ostwal V, Harris C, Sirohi B, Goel M, Bal M, Kannan S,Shrikhande SV. Role of adjuvant chemotherapy in T2N0M0 periampullary cancers. Asia Pac J Clin Oncol. 2016 Dec 28. doi: 10.1111/ajco.12612. [Epub ahead of print] PMID:28029222
  3. Shrikhande SV, Sivasanker M, Vollmer CM, Friess H, Besselink MG, Fingerhut A, Yeo CJ, Fernandez-delCastillo C, Dervenis C, Halloran C, Gouma DJ, Radenkovic D, Asbun HJ, Neoptolemos JP, Izbicki JR, Lillemoe KD, Conlon KC, Fernandez-Cruz L, Montorsi M, Bockhorn M, Adham M, Charnley R, Carter R, Hackert T, Hartwig W, Miao Y, Sarr M, Bassi C, Büchler MW. Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2016 Dec 24. pii: S0039-6060(16)30764-4. doi: 10.1016/j.surg.2016.11.021. [Epub ahead of print] Review. PMID: 28027816
  4. Barreto SG, Sirohi B,Shrikhande SV. Timing of rectal cancer surgery following neoadjuvant chemoradiation: how close are we to striking an equipoise? Future Oncol. 2016 Nov 23. PMID: 27875904
  5. Are C1,Chowdhury S2, Ahmad H3, Ravipati A4, Song T5, Shrikandhe S6, Smith L7. Predictive global trends in the incidence and mortality of pancreatic cancer based on geographic location, socio-economic status, and demographic shift. J Surg Oncol. 2016 Nov; 114(6):736-742. doi: 10.1002/jso.24410. Epub 2016 Aug 11.
  6. Besselink MG, van Rijssen LB, Bassi C, Dervenis C, Montorsi M, Adham M, Asbun HJ, Bockhorn M, Strobel O, Büchler MW, Busch OR, Charnley RM, Conlon KC, Fernández-Cruz L, Fingerhut A, Friess H, Izbicki JR, Lillemoe KD, Neoptolemos JP, Sarr MG,Shrikhande SV, Sitarz R, Vollmer CM, Yeo CJ, Hartwig W, Wolfgang CL, Gouma DJ; Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery. International Study Group on Pancreatic Surgery. 2016 Sep 28. pii: S0039-6060(16)30417-2. doi: 10.1016/j.surg.2016.06.058. PMID:27692778
  7. Khan SA, Amnekar R, Khade B, Barreto SG, Ramadwar M,Shrikhande SV, Gupta S. p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer. Clin Epigenetics. 2016 Aug 31;8:88. doi: 10.1186/s13148-016-0255-9. eCollection 2016. PMID:27588146
  8. Basu S, Ranade R, Ostwal V,Shrikhande SV. PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine Tumors. PET Clin. 2016 Jul; 11(3):233-41. doi: 10.1016/j.cpet.2016.02.004. Epub 2016 Apr 25. Review. PMID:27321028
  9. Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Performance of 177Lu-DOTATATE- based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics. Nucl Med Commun. 2016 May 27. PMID: 27243215
  10. Masillamany Sivasanker, Chaitali Nashikkar, Shailesh V. Shrikhande. Data Integrity In Clinical Trials – A Clinical Investigator’s perspective. Pharma Times – Vol. 48 – No. 05 – May 2016
  11. Ramaswamy A, Ostwal V, Shetty O, Sahu A, Paul D, Pai T, Gurav M, Shetty N,Shrikhande S. Neoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?. J Gastrointest Cancer. 2016 May 24. PMID: 27217036
  12. Dawood S, Sirohi B,Shrikhande SV, Toh HC, Eng C. Potential Prognostic Impact of Baseline CEA Level and Surgery of Primary Tumor Among Patients with Synchronous Stage IV Colorectal Cancer: A Large Population Based Study. Indian J Surg Oncol. 2015 Sep;6(3):198-206. doi: 10.1007/s13193-015-0419-7. Epub 2015 Jun 7.PMID: 27217664
  13. Anant Ramaswamy, Deepak Jain, Arvind Sahu, Joydeep Ghosh, Priya Prasad, Kedar Deodhar, Nitin Shetty, Shripad Banavali, Shailesh Shrikhande, Vikas Ostwal. Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib. J Gastrointest Oncol 2016. doi: 10.21037/ jgo.2016.03.13
  14. Sugoor P, Shah S, Dusane R, Desouza A, Goel M,Shrikhande SV. Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary. Langenbecks Arch Surg. 2016 May 4. PMID: 27143021
  15. Patil RS, Shah SU,Shrikhande SV, Goel M, Dikshit R, Chiplunkar SV. IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients. Int J Cancer. 2016 Apr 8. doi: 10.1002/ijc.30134. PMID: 27062572
  16. Engineer R, Goel M, Chopra S, Patil P, Purandare N, Rangarajan V, Ph R, Bal M,Shrikhande S, Shrivastava SK, Mehta S. Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm. Ann Surg Oncol. 2016 Apr 13. PMID:27075323
  17. Sahu A, Godbole S, Jain P, Ghosh J,Shrikhande S, Ramadwar M, Goyal M, Gulia S, Bajpai J, Kembhavi Y, Gupta S. Sunitinib in patients with imatinib-resistant gastrointestinal stromal tumor: A single center experiencep-190 chronic myelogenous leukemia presenting as extramedullary blast crisis. Indian J Cancer. 2015 Jul-Sep;52(3):320-3. doi: 10.4103/0019-509X.176747. PMID: 26905126
  18. Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR,Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. Infect Agent Cancer. 2016 Mar 3;11:12. doi: 10.1186/s13027-016-0057-x. eCollection 2016. PMID: 26941832
  19. Sirohi B, Dawood S, Rastogi S, Pandey A, Bal M, Shetty N,Shrikhande SV. Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer center. Indian J Cancer. 2015 Jul-Sep;52(3):449-52. doi: 10.4103/0019-509X.176732. PMID: 26905166
  20. Goroshi M, Bandgar T, Lila AR, Jadhav SS, Khare S,Shrikhande SV, Uchino S, Dalvi AN, Shah NS. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. Fam Cancer. 2016 Feb 23. PMID: 26905068
  21. Bankar S, Patkar S, Desai S,Shrikhande SV. Unusual presentation of melanoma of unknown primary origin: A case report and review of literature. J Cancer Res Ther. 2015 Oct-Dec;11(4):1025. doi: 10.4103/0973-1482.148680. PMID: 26881591
  22. Goel M, Tamhankar A, Rangarajan V, Patkar S, Ramadwar M,Shrikhande SV. Role of PET CT scan in redefining treatment of incidental gall bladder carcinoma. J Surg Oncol. 2016 Feb 5. doi: 10.1002/jso.24198. PMID:26847023
  23. Batra S, Suradkar K, Talole S, Desouza A, Goel M,Shrikhande SV. Major Gastrointestinal Cancer Resections in the Elderly in India: Poised for Future Challenges. Dig Surg. 2016 Jan 29;33(2):146-156. PMID: 26820472
  24. Gomes RM, Bal M, Patkar S, Goel M,Shrikhande SV. Unexpected benign histopathology after pancreatoduodenectomy for presumed malignancy: accepting the inevitable. Langenbecks Arch Surg. 2016 Jan 26. PMID: 26811147.
  25. Mitra A, D’Souza A, Goel M,Shrikhande SV. Surgery for Pancreatic and Periampullary Carcinoma. Indian J Surg. 2015 Oct;77(5):371-80. doi: 10.1007/s12262-015-1358-9. Epub 2015 Oct 10. PMID:26722199
  26. Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A, D’Cruz A, Eggermont AM, Fleming K, Gueye SM, Hagander L, Herrera CA, Holmer H, Ilbawi AM, Jarnheimer A, Ji JF, Kingham TP, Liberman J, Leather AJ, Meara JG, Mukhopadhyay S, Murthy SS, Omar S, Parham GP, Pramesh CS, Riviello R, Rodin D, Santini L,Shrikhande SV, Shrime M, Thomas R, Tsunoda AT, van de Velde C, Veronesi U, Vijaykumar DK, Watters D, Wang S, Wu YL, Zeiton M, Purushotham A. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015 Sep; 16(11):1193-224. doi: 10.1016/S1470-2045(15)00223-5. Review. PMID: 26427363
  27. Shrikhande SV, Sivasanker M. Laparoscopic pancreatoduodenectomy: How far have we come and where are we headed? World J Gastrointest Surg. 2015 Aug 27; 7(8):128-32. doi: 10.4240/wjgs.v7.i8.128. PMID: 26328031
  28. Shetty N, Sirohi B, Shrikhande SV. Molecular target therapy for gastrointestinal stromal tumors. Transl Gastrointest Cancer 2015; 4 (3):207-218. doi: 10.3978/j.issn.2224-4778.2015.04.02
  29. Sirohi B, Mitra A, Jagannath P, Singh A, Ramadvar M, Kulkarni S, Goel M,Shrikhande SV. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015 May; 11 (10):1501-9. doi: 10.2217/fon.14.308. PMID: – 25963427
  30. Sirohi B, Singh A, Dawood S,Shrikhande SV. Advances in chemotherapy for pancreatic cancer. Indian J Surg Oncol. 2015 Mar; 6(1):47-56. doi: 10.1007/s13193-014-0371-y. Epub 2015 Jan 13. Review. PMID: 25937764
  31. Shetty PS, Patkar S, Shet T, Goel M,Shrikhande SV. Castleman’s Disease Presenting as Peri – Pancreatic Neoplasm. Indian J Surg Oncol. 2015 Mar;6(1):26-9. doi: 10.1007/s13193-014-0343-2. Epub 2014 Aug 28. PMID: 25937760
  32. Penumadu P, Barreto SG, Goel M,Shrikhande SV. Pancreatoduodenectomy – preventing complications. Indian J Surg Oncol. 2015 Mar;6(1):6-15. doi: 10.1007/s13193-013-0286-z. Epub 2014 Jan 19. PMID:- 25937757
  33. Sirohi B1,Rastogi S, Singh A, Sheth V, Dawood S, Talole S, Ramadwar M, Kulkarni S, Shrikhande SV. Use of gemcitabine-platinum in Indian patients with advanced gall bladder cancer. Future Oncol. 2015;11(8):1191-200. doi: 10.2217/fon.14.295.
  34. Bal MM, Ramadwar M, Deodhar K,Shrikhande S. Pathology of Gallbladder Carcinoma: Current Understanding and New Perspectives. Pathol Oncol Res. 2015 Jan 25. [Epub ahead of print] PMID:-25618479.
  35. Shrikhande SV, Gaikwad V, Desouza A, Goel M. Is Laparoscopic Surgery the Standard of Care for GI Luminal Cancer? Indian J Surg. 2014 Dec;76(6):444-52. doi: 10.1007/s12262-014-1126-2. Epub 2014 Jun 25.
  36. Sirohi B, Barreto SG, Singh A, Batra S, Mittra A, Rastogia S, Ramadwar M, Shetty N, Goel M, Shrikhande SV. Epirubicin, oxaliplatin, and capectabine is just as “MAGIC”al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer. J Cancer Res Ther. 2014 Oct-Dec;10(4):866-70. doi: 10.4103/0973-1482.146122.
  37. Sirohi B, Barreto SG, Patkar S, Gupta A, DeSouza A, Talole S, Deodhar K, Shetty N, Engineer R, Goel M,Shrikhande SV. Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter? Indian J Med Paediatr Oncol. 2014 Oct; 35(4):263-6. doi: 10.4103/0971-5851.144986.
  38. Shrikhande SV, Sirohi B, Barreto SG, Chacko RT, Parikh PM, Pautu J, Arya S, Patil P, Chilukuri SC, Ganesh B, Kaur T, Shukla D, Rath GS. Indian Council of Medical Research consensus document for the management of gastrointestinal stromal tumors. Indian J Med Paediatr Oncol. 2014 Oct; 35(4):244-8. doi: 10.4103/0971-5851.144983.
  39. Shrikhande SV, Sirohi B, Barreto SG, Chacko RT, Parikh PM, Pautu J, Arya S, Patil P, Chilukuri SC, Ganesh B, Kaur T, Shukla D, Rath GS. Indian Council of Medical Research consensus document for the management of gastric cancer. Indian J Med Paediatr Oncol. 2014 Oct; 35(4):239-43. doi: 10.4103/0971-5851.144970.
  40. Singh S, Chakravarthy M, Rosenthal VD, Myatra SN, Dwivedy A, Bagasrawala I, Munshi N, Shah S, Panigrahi B, Sood S, Kumar-Nair P, Radhakrishnan K, Gokul BN, Sukanya R, Pushparaj L, Pramesh CS,Shrikhande SV, Gulia A, Puri A, Moiyadi A, Divatia JV, Kelkar R, Biswas S, Raut S, Sampat S, Shetty S, Binu S, Pinto P, Arora S, Kamble A, Kumari N, Mendonca A, Singhal T, Naik R, Kothari V, Sharma B, Verma N, Khanna DK, Chacko F. Surgical site infection rates in 6 cities of India: findings of the International Nosocomial Infection Control Consortium (INICC). Int Health. 2014 Dec 8. pii: ihu089. PMID: 25487724
  41. Sirohi B, Shrikhande SV, Perakath B, Raghunandharao D, Julka PK, Lele V, Chaturvedi A, Nandakumar A, Ramadwar M, Bhatia V, Mittal R, Kaur T, Shukla DK, Rath GK. Indian Council of Medical Research consensus document for the management of colorectal cancer. Indian J Med Paediatr Oncol. 2014 Jul;35(3):192-6.
  42. Pai E, Shrikhande SV. Drainage After Pancreaticoduodenectomy: To Step Back May Be the Way Forward, but Are Randomized Controlled Trials Making Us Any Wiser? Ann Surg. 2014 Sep 19. PMID: 25243556.
  43. Khan SA, Tyagi M, Sharma AK, Barreto SG, Sirohi B, Ramadwar M,Shrikhande SV, Gupta S. Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma. World J Gastroenterol. 2014 Sep 14;20(34):12202-11. doi: 10.3748/wjg.v20.i34.12202. PMID: 25232253.
  44. Sirohi B, Rastogi S, Dawood S, Talole S, Ramadwar M, Shetty N,Shrikhande SV. Treatment of patients with advanced gastric cancer: experience from an Indian tertiary cancer center. Med Oncol. 2014 Oct; 31(10):138. doi: 10.1007/s12032-014-0138-x. Epub 2014 Sep 17.PMID:25228200.
  45. Sirohi B, Gupta S, Raghunadharao D, Shrikhande SV. Clinical trials in India: At uncertain crossroads? Indian J Med Paediatr Oncol. 2014 Apr; 35(2):133-5. doi: 10.4103/0971-5851.138947. No abstract available. PMID: 25197173 [PubMed].
  46. Sirohi B1, Philip DS, Shrikhande SV. Regorafenib in gastrointestinal stromal tumors. Future Oncol. 2014 Aug; 10(9):1581-7. doi: 10.2217/fon.14.101.
  47. Yadav K, Shrikhande S, Goel M. Post Hepatectomy Liver Failure: Concept of Management. J Gastrointest Cancer. 2014 Aug 8. [Epub ahead of print].
  48. Bhawna Sirohi , Ashish Singh, Jagannath and Shailesh V. Shrikhande. Chemotherapy and Targeted Therapy for Gall Bladder Cancer. Indian Journal of Surgical Oncology © Indian Association of Surgical Oncology 2014. 10.1007/s13193-014-0317-4.
  49. Tol JA, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun HJ, Bockhorn M, Büchler MW, Conlon KC, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki JR, Lillemoe KD, Milicevic MN, Neoptolemos JP, Shrikhande SV, Vollmer CM, Yeo CJ, Charnley RM; International Study Group on Pancreatic Surgery. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2014 Jul 22. pii: S0039-6060(14)00355-9. doi: 10.1016/j.surg.2014.06.016. [Epub ahead of print].
  50. Goel M, Gaikwad V, Dharia T, Kulkarni S, Shetty N, Shrikhande SV. Preresection transarterial chemoembolization for hepatocellular carcinoma: An experience with 23 patients. Indian J Gastroenterol. 2014 Jul 19. [Epub ahead of print].
  51. Shrikhande SV, Pai E. Enhanced recovery after surgery in laparoscopic gastric cancer surgery: Many questions, few answers. J Minim Access Surg. 2014 Jul;10(3):105-6. doi: 10.4103/0972-9941.134871. PMID 25013324 [PubMed].
  52. Basu S, Sirohi B, Shrikhande SV. Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT. Eur J Nucl Med Mol Imaging. 2014 May 27. [Epub ahead of print]
  53. Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, Andrén-Sandberg A, Asbun HJ, Bassi C, Bockhorn M, Charnley R, Conlon KC, Dervenis C, Fernandez-Cruz L, Friess H, Gouma DJ, Imrie CW, Lillemoe KD, Milićević MN, Montorsi M, Shrikhande SV, Vashist YK, Izbicki JR, Büchler MW; International Study Group on Pancreatic Surgery. Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery. 2014 Feb 20. pii: S0039-6060(14)00058-0. doi: 10.1016/j.surg.2014.02.009. [Epub ahead of print]
  54. Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Büchler M, Charnley RM, Conlon K, Cruz LF, Dervenis C, Fingerhutt A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR; International Study Group of Pancreatic Surgery. Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014 Jun;155(6):977-88. doi: 10.1016/j.surg.2014.02.001. Epub 2014 Feb 7.
  55. Bhandare S,Shrikhande S, Bakshi G, Deodhar KK. Isolated adrenal metastasis: A case r130932.eport. Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):150-1. doi: 10.4103/0377-
  56. Asbun HJ, Conlon K, Fernandez-Cruz L, Friess H, Shrikhande SV, Adham M, Bassi C, Bockhorn M, Büchler M, Charnley RM, Dervenis C, Fingerhutt A, Gouma DJ, Hartwig W, Imrie C, Izbicki JR, Lillemoe KD, Milicevic M, Montorsi M, Neoptolemos JP, Sandberg AA, Sarr M, Vollmer C, Yeo CJ, Traverso LW; International Study Group of Pancreatic Surgery. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery. 2014 May;155(5):887-892. doi: 10.1016/j.surg.2013.12.032. Epub 2014 Jan 2.
  57. Shrikhande SV. Whipple resection: The need for specialization, standardization and centralization. South Asian J Cancer. 2013 Jul;2(3):158-9. doi: 10.4103/2278-330X.114143.
  58. Sirohi B, Shrikhande SV. Cystic lesions of the pancreas: Improved understanding, diagnostics and refined outcomes. South Asian J Cancer. 2013 Jul;2(3):151-2. doi: 10.4103/2278-330X.114138.
  59. Shrikhande SV, Gaikwad V, Purohit D, Goel M. Major abdominal cancer resections in cirrhotic patients: How frequent is postoperative hepatocellular decompensation? Indian J Gastroenterol. 2013 Nov 12. [Epub ahead of print]
  60. Barreto SG, Pawar S, Shah S, Talole S, Goel M, Shrikhande SV. Patterns of Failure and Determinants of Outcomes Following Radical Re-resection for Incidental Gallbladder Cancer. World J Surg. 2014 Feb;38(2):484-9. doi: 10.1007/s00268-013-2266-4.
  61. Barreto SG, Chaubal GN, Talole S, Desouza A, Suradkar K, Gaikwad V, Goel M, Shrikhande SV. Rectal cancer in young Indians-Are these cancers different compared to their older counterparts? Indian J Gastroenterol. 2014 Mar;33(2):146-50. doi: 10.1007/s12664-013-0396-0. Epub 2013 Sep 19.
  62. Rosenthal VD, Richtmann R, Singh S et al. (Shrikhande SV – collaborator). Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. doi: 10.1086/670626. Epub 2013 Apr 18.
  63. Shrikhande SV, Barreto SG, Shetty G, Suradkar K, Bodhankar YD, Shah SB, Goel M. Post-operative abdominal drainage following major upper gastrointestinal surgery: Single drain versus two drains. J Cancer Res Ther. 2013 Apr-Jun;9(2):267-71. doi: 10.4103/0973-1482.113380.
  64. Sirohi B, Philip DS, Shrikhande SV. Regorafenib: carving a niche in the crowded therapeutic landscape. Expert Rev Anticancer Ther. 2013 Apr;13(4):385-93. doi: 10.1586/era.13.12.
  65. Shrikhande S (Collaborator), Melloul E, Raptis DA, Clavien PA, Lesurtel M; European-African Hepato-Pancreato-Biliary Association. Poor level of agreement on the management of postoperative pancreatic fistula: results of an international survey. HPB (Oxford). 2013 Apr;15(4):307-14. doi: 10.1111/j.1477-2574.2012.00599.x. Epub 2012 Oct 24.
  66. Shrikhande SV, Barreto SG, Somashekar BA, Suradkar K, Shetty GS, Talole S, Sirohi B, Goel M, Shukla PJ. Evolution of pancreatoduodenectomy in a tertiary cancer center in India: improved results from service reconfiguration. 2013 Jan-Feb;13(1):63-71. doi: 10.1016/j.pan.2012.11.302. Epub 2012 Nov 10.
  67. Shrikhande SV, Barreto SG, Talole SD, Vinchurkar K, Annaiah S, Suradkar K, Mehta S, Goel M. D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy. World J Surg Oncol. 2013 Feb 2;11(1):31. [Epub ahead of print]
  68. Shrikhande SV, Barreto SG. Surgery for Pancreatic Carcinoma: State of the Art. Indian J Surg. 2012 Feb;74(1):79-86. Epub 2011 Nov 24.
  69. Engineer R, Mohandas KM, Shukla PJ, Shrikhande SV, Mahantshetty U, Chopra S, Goel M, Mehta S, Patil P, Ramadwar M, Deodhar K, Arya S, Shrivastava SK. Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. Int J Colorectal Dis. 2013 Jan 29. [Epub ahead of print]
  70. Shrikhande SV, Sirohi B, Goel M, Barreto SG. Pancreatic neuroendocrine tumors. Indian J Gastroentero 2012 Oct 3.
  71. Bal MM, Deodhar K, Shrikhande S, Shukla P, Arya S, Ramadwar M. Solid pseudopapillary tumor of the pancreas: ‘Experiences’ and ‘Lessons’ at a tertiary-care oncology center. Diagn Cytopathol. 2012 Sep 25. doi: 10.1002/dc.22908.
  72. Shrikhande SV, Barreto SG, Goel M, Arya S. Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB (Oxford). 2012 Oct; 14(10):658-68.
  73. Shrikhande SV, Bodhankar YD, Suradkar K, Goel M, Shukla PJ. Perioperative outcomes after ultra low anterior resection in the era of neoadjuvant chemoradiotherapy. Indian J Gastroenterol. 2012 Aug14.
  74. Shrikhande SV, Gupta S, Ostwal V. Metastatic pancreatic cancer: another option?Natl Med J India 2011 Nov-Dec;24(6):356-7.
  1. Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA. ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg. 2012 May 9. doi: 10.1002/bjs.8763.
  2. Deodhar KK, Budukh A, Ramadwar M, Bal MM, Shrikhande SV. Are we achieving the benchmark of retrieving 12 lymph nodes in colorectal carcinoma specimens? Experience from a tertiary referral center in India and review of literature. Indian J Pathol Microbiol. 2012;55:38-42.
  3. Shrikhande SV, Marda SS, Suradkar K, Arya S, Shetty GS, Bal M, Shukla PJ, Goel M, Mohandas KM. Gastrointestinal stromal tumors: case series of 29 patients defining the role of imatinib prior to surgery. World J Surg. 2012;36:864-71.
  4. Jagannath P, Chhabra D, Shrikhande S, Shah R. Surgical treatment of liver metastases in neuroendocrine neoplasms. Int J Hepatol. 2012;2012:782672. Epub 2012 Jan 26
  5. Shetty GS, Bodhankar YD, Ingle S, Thakkar RG, Goel M, Shukla PJ, Shrikhande SV. Complications as indicators of quality assurance after 401 consecutive colorectal cancer resections: the importance of surgeon volume in developing colorectal cancer units in India. World J Surg Oncol. 2012 Jan. PMID: 22257531 [PubMed – in process]
  6. Qureshi SS, Shrikhande S, Ramadwar M, Desai S, Visvanathan S, Medhi SS, Laskar S, Muckaden MA, Pai SK, Desai S, Kurkure PA. Desmoplastic small round cell tumor of the pancreas: An unusual primary site for an uncommon tumor. J Indian Assoc Pediatr Surg. 2011;16(2):66-8.
  7. Shukla PJ, Barreto G, Shrikhande SV. The evolution of pancreatoduodenectomy. Hepatogastroenterology. 2011;58(109):1409-12. doi: 10.5754/hge08129.
  8. Shukla PJ, Barreto SG, Pandey D, Kanitkar GA, Shrikhande SV. Managing leaks following anterior resections: a new classification system. Hepatogastroenterology. 2011;58(109):1095-8. doi: 10.5754/hge07492.
  9. Shrikhande SV, Barreto SG, Bodhankar YD, Suradkar K, Shetty G, Hawaldar R, Goel M, Shukla PJ. Superior mesenteric artery first combined with uncinate process approach versus uncinate process first approach in pancreatoduodenectomy: a comparative study evaluating perioperative outcomes. Langenbecks Arch Surg. 2011 Jul 8. [Epub ahead of print]
  10. Shrikhande SV, Arya S, Barreto SG, Ingle S, D’Souza MA, Hawaldar R, Shukla PJ. Borderline resectable pancreatic tumors: Is there a need for further refinement of this stage? Hepatobiliary Pancreat Dis Int. 2011;10:319-24.
  11. Maharaj R, Sakpal SV, Deodhar K, Kulkarni A, Arya S, Ramadwar M, Shrikhande SV, Naraynsingh V, Shukla PJ. A cystic hepatic lesion: when to worry? West Indian Med J. 2010;59:226-9.
  12. Myatra S, Divatia JV, Jibhkate B, Barreto GS, Shrikhande SV. Preoperative assessment and optimization in periampullary and pancreatic cancer. Indian J Cancer. 2011 Jan 20. [Epub ahead of print]
  13. Shrikhande SV, Marda S, Goel M, Shetty G. Laparoscopic surgery for rectal cancer. Lancet Oncol. 2010;11(10):919-20.
  14. Gillen S, Kleeff J, Kranzfelder M, Shrikhande SV, Friess H, Feussner H. Natural orifice transluminal endoscopic surgery in pancreatic diseases. World J Gastroenterol. 2010 21;16(31):3859-64.
  15. D’souza MA, Singh K, Hawaldar RV, Shukla PJ, Shrikhande SV. The vascular stapler in uncinate process division during pancreaticoduodenectomy: technical considerations and results. Dig Surg. 2010;27:175-81. Epub 2010 Jun 22.
  16. Shrikhande SV, Barreto SG, Singh S, Udwadia TE, Agarwal AK. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause! Eur J Surg Oncol. 2010;36:514-9. Epub 2010 May 26
  17. Barreto SG, Shukla PJ, Shrikhande SV. Tumors of the Pancreatic Body and Tail. World Journal of Oncology 2010;1(2):52-65.
  18. Shukla PJ, Barreto SG, Bedi M, Bheerappa N, Chaudhary A, Gandhi M, Jacob M, Jesvanth S, Kannan D, Kapoor VK, Kumar A, Maudar K, Ramesh H, Sastry R, Saxena R, Sewkani A, Sharma S, Shrikhande SV, Singh A, Singh RK, Surendran R, Varshney S, Verma V, Vimalraj V. Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study. HPB (Oxford). 2009;11:638-44.
  19. Kuenzli BM, Friess H, Shrikhande SV. Is Laparoscopic Colorectal Cancer Surgery equal to open surgery? An evidence based perspective. (Invited Topic Highlight) WJGS 2010;2:101-108.
  20. Shrikhande SV, Barreto SG. Extended Pancreatic Resections and Lymphadenectomy: An appraisal of the current evidence. (Invited Topic Highlight) WJGS 2010;2:39-46.
  21. Shrikhande SV, Barreto SG. Surgery for Gall Bladder Cancer: The need to generate higher evidence. WJGS 2009;1:26-29.
  22. Shrikhande SV, Shetty GS, Singh K, Ingle S. Is early enteral feeding after major gastrointestinal surgery a fashion or an advance? An evidence based review of the literature. J Cancer Res Ther. 2009;5:232-9
  23. D’souza MA, Singh K, Shrikhande SV. Surgery for gastric cancer: An evidence based perspective. Cancer Res Ther. 2009;5:225-31.
  24. Shetty GS, Shukla PJ, Shrikhande SV. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer (Br J Surg 2009; 96: 462-472). Br J Surg. 2009 Oct 21;96(11):1374-1375. [Epub ahead of print]
  25. Barreto SG, Shet T, Shrikhande SV, Shukla PJ. Synchronous papillary thyroid carcinoma with mucinous rectal carcinoma. Indian J Pathol Microbiol. 2009;52:577-9.
  26. Shrikhande SV, Barreto G, Koliopanos A. Pancreatic carcinogenesis: The impact of chronic pancreatitis and its clinical relevance. Indian J Cancer. 2009;46:288-96
  27. Barreto SG, Shukla PJ, Shrikhande SV. Small intestinal tumours. J Coll Physicians Surg Pak. 2009;19(7):459-63.
  28. Shrikhande SV, D’Souza MA, Wente MN. Pancreaticoduodenectomy in India: how far are we from centralization? 2009;38(4):473-5.
  29. Shukla PJ, Barreto SG, Hawaldar R, Nadkarni M, Kanitkar GA, Kerkar R, Shrikhande SV. Feasibility of laparoscopic abdomino – perineal resection for large – sized anorectal cancers: A single – institution experience of 59 cases. Indian J Med Sci. 2009;63:109-14
  30. Shukla PJ, Barreto SG, Mohandas KM, Shrikhande SV. Defining the role of surgery for complications after pancreatoduodenectomy. ANZ J Surg. 2009;79(1-2):33-7.
  31. Pasupathy S, Goh BK, Shrikhande SV, Mesenas SJ. Is there a place for NOTES in the diagnosis and treatment of neoplastic lesions of the pancreas? Surg Oncol. 2009 Jan 19. [Epub ahead of print].
  32. Shukla PJ, Barreto SG, Arya S, Shrikhande SV, Hawaldar R, Purandare N, Rangarajan V. Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer? HPB (Oxford). 2008;10:439-45.
  33. Puri A, Agarwal MG, Shah M, Srinivas CH, Shukla PJ, Shrikhande SV, Jambhekar NA. Decision making in primary sacral tumors. Spine J. 2008 Dec 5. [Epub ahead of print]
  34. Barreto G, D’Souza MA, Shukla PJ, Shrikhande SV. The gray zone between postpancreaticoduodenectomy collections and pancreatic fistula. 2008;37:422-5.
  35. Shrikhande SV, D’Souza MA. Pancreatic fistula after pancreatectomy: Evolving definitions, preventive strategies and modern management. (Invited Topic Highlight) World J Gastroenterol. 2008;14:5789-96.
  36. Shukla PJ, Barreto SG, Shrikhande SV, Ramadwar MR, Deodhar KK, Mehta S, Patil P, Mohandas KM. Simultaneous gallbladder and bile duct cancers: revisiting the pathological possibilities. HPB (Oxford). 2008;10:48-53.
  37. Shukla PJ, Barreto G, Kakade A, Shrikhande SV. Revision surgery for incidental gallbladder cancer: factors influencing operability and further evidence for T1b tumours. HPB (Oxford). 2008;10:43-7.
  38. Shukla PJ, Siddachari R, Ahire S, Arya S, Ramani S, Barreto SG, Gupta S, Shrikhande SV, Jagannath P, Desouza LJ. Postoperative deep vein thrombosis in patients with colorectal cancer. Indian J Gastroenterol. 2008;27:71-3.
  39. D’souza MA, Shrikhande SV. Pancreatic resectional surgery: an evidence-based perspective. J Cancer Res Ther. 2008;4:77-83
  40. Shukla PJ, Neve R, Barreto SG, Hawaldar R, Nadkarni MS, Mohandas KM, Shrikhande SV. A New Scoring System for Gallbladder Cancer (Aiding Treatment Algorithm): An Analysis of 335 Patients. Ann Surg Oncol. 2008 May 6 [Epub ahead of print]
  41. Shukla PJ, Barreto SG, Qureshi SS, Hawaldar R, Shrikhande SV, Ramadwar MR, Banavali S. Hepatoblastoma: a single institutional experience of 18 cases. Pediatr Surg Int. 2008 May 6 [Epub ahead of print]
  42. Shukla PJ, Barreto SG, Shrikhande SV, Mohandas KM, Purandare N, Rangarajan V. Detection of gall bladder cancer metastases in rare sites by PET scan. Indian J Gastroenterol. 2007;26:303-4.
  43. Barreto SG, Shukla PJ, Shrikhande SV. Vitamin D3 in operable periampullary and pancreatic cancer: perioperative outcomes in a pilot study assessing safety. Pancreas 2008;36:315-7.
  44. Shaikh S, Arya S, Ramadwar M, Barreto SG, Shukla PJ, Shrikhande SV. Three cases of unusual solid pseudopapillary tumors. Can radiology and histology aid decision-making? JOP 2008;9:150-9.
  45. Shrikhande SV, Kleeff J, Buchler MW, Friess H. Pancreatic anastomosis after pancreaticoduodenectomy: How we do it. Ind J Surg 2007;6:224-29.
  46. Shukla PJ, Barreto G, Neve R, Mohandas KM, Shrikhande SV. Can we do better than ‘incidental’ gallbladder cancer? 2007;54:2184-5.
  47. Barreto G, Shrikhande S, Shukla P. Gastric cancer presenting with cutaneous metastasis. Indian J Gastroenterol. 2007;26(5):237.
  48. Shukla PJ, Barreto SG, Shrikhande SV. Enucleation of pancreatic neoplasms (Br J Surg 2007; 94: 1254-1259). Br J Surg. 2008;95:261; author reply 261-2.
  49. Shukla PJ, Barreto G, Shrikhande SV. Retroperitoneal Sarcoma. Br J Surg 2007;94:1572.
  50. Shukla PJ, Barreto G, Pandey D, Kanitkar G, Nadkarni MS, Neve R, Shrikhande SV. Modification in the technique of pancreaticoduodenectomy: supracolic division of jejunum to facilitate uncinate process division. Hepatogastroenterology 2007;54:1728-30.
  51. Punpale AS, Shrikhande SV, Sumeet G, Shukla PJ. Primary neuroendocrine carcinoma presenting as mesenteric cyst. Indian J Gastroenterol. 2007 May-Jun;26(3):137-8.
  52. Shrikhande SV, Barreto G, Shukla PJ. Pancreatic fistula after pancreaticoduodenectomy: the impact of a standardized technique of pancreaticojejunostomy. Langenbecks Arch Surg. 2008;393(1):87-91. Epub 2007 Aug 17.
  53. Shukla PJ, Barreto SG, Gupta P, Neve R, Ramadwar M, Deodhar K, Mehta S, Shrikhande SV, Mohandas KM. Is there a role for estrogen and progesterone receptors in gall bladder cancer? HPB 2007;9:285-88.
  54. Barreto SG, Shukla PJ, Ramadwar M, Arya S, Shrikhande SV. Cystic tumours of the pancreas. HPB 2007;9:259 – 66.
  55. Shrikhande SV, Barreto SG, Shukla PJ. Laparoscopy in pancreatic tumors. J Min Access Surg 2007;3:47-51.
  56. Shukla PJ, Barreto G, Shrikhande SV. Is it possible to retrospectively evaluate multivisceral resections for locally advanced colorectal cancer in a population? Natl Med J India 2007;20:22-3.
  57. Barreto G, Neve R, Shrikhande SV, Shukla PJ. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg. 2007;94(5):644; author reply 644-5.
  58. Shrikhande SV, Saoji RR, Barreto SG, Kakade AC, Waterford SD, Ahire SB, Goliwale FM, Shukla PJ. Outcomes of resection for rectal cancer in India: The impact of the double stapling technique. World J Surg Oncol 2007 Mar 21;5(1):35 [Epub ahead of print].
  59. Barreto G, Shrikhande SV, Shukla PJ. Hepatocellular carcinoma. Bombay Hospital Journal 2007;49:143-60.
  60. Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, Buchler MW. Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 2007;193:171-83.
  61. Shrikhande SV, Kleeff J, Kayed H, Keleg S, Reiser C, Giese T, Buchler MW, Esposito I, Friess H. Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells. Anticancer Res. 2006;26(5A):3265-73.
  62. Shukla PJ, Barreto G, Gupta P, Shrikhande SV. Laparoscopic surgery for colorectal cancers: Current status. J Min Access Surg 2006;2:205-210.
  63. Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Buchler MW. Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 2006 Oct 25; [Epub ahead of print]
  64. Pandey D, Kane SV, Shukla PJ, Shrikhande SV, Tongaonkar HB. Isolated gall bladder metastasis from renal cell carcinoma. Indian J Gastroenterol 2006;25(3):161-2.
  65. Wente MN, Shrikhande SV, Kleeff J, Muller MW, Gutt CN, Buchler MW, Friess H. Management of early haemorrhage from pancreatic anastomosis after pancreaticoduodenectomy. Dig Surg 2006 Jul 26;23(4):203-208 [Epub ahead of print].
  66. Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 2006;23:192-197.
  67. Shrikhande SV, Buchler P, Esposito I, Loos M, Buchler MW, Friess H. Splenic and portal vein thrombosis in pancreatic metastasis from Renal cell carcinoma. World J Surg Oncol 2006;4:25.
  68. Shrikhande SV, Kleeff J, Friess H, Buchler MW. Management of pain in small duct chronic pancreatitis. J Gastrointest Surg 2006;10:227-33.
  69. Shrikhande SV, Qureshi SS, Rajneesh N, Shukla PJ. Pancreatic anastomoses after pancreaticoduodenectomy: do we need further studies? World J Surg 2005 ;29:1642-9.
  70. Patil TB, Shrikhande SV, Kanhere HA, Saoji RR, Ramadwar MR, Shukla PJ. Solid pseudopapillary neoplasm of the pancreas: a single institution experience of 14 cases. HPB 2005;7:1-3
  71. Jain PN, Shrikhande SV, Myatra SN, Sareen R. Neurolytic celiac plexus block: a better alternative to opioid treatment in upper abdominal malignancies: an Indian experience. J Pain Palliat Care Pharmacother 2005;19(3):15-20.
  72. Bachmann J, Kleeff J, Bergmann F, Shrikhande SV, Hartschuh W, Buchler MW, Friess H. Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: Case report and literature review. World J Surg Oncol 2005 Sep 1;3:58.
  73. Qureshi SS, Shrikhande SV, Tanuja S, Shukla PJ. Breast metastases of gastric signet ring cell carcinoma: A differential diagnosis with primary breast signet ring cell carcinoma. J Postgrad Med 2005 Apr-Jun;51(2):125-7.
  74. Shukla PJ, Qureshi SS, Shrikhande SV, Jagannath P, Desouza LJ. Reoperative pancreaticoduodenectomy for periampullary carcinoma. ANZ J Surg 2005 Jul;75(7):520-3.
  75. Shukla PJ, Pandey D, Rao PP, Shrikhande SV, Thakur MH, Arya S, Ramani S, Mehta S, Mohandas KM. Impact of intra-operative ultrasonography in liver surgery. Indian J Gastroenterol 2005 Mar-Apr;24(2):62-5.
  76. Jagannath P, Dhir V, Shrikhande S, Shah RC, Mullerpatan P, Mohandas KM. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg 2005 Mar;92(3):356-61.
  77. Qureshi SS, Nadkarni MS, Shrikhande SV, Desai S, Deodhar K, Ramadwar M, Shukla PJ. Hepatic resection for metastasis from adenoid cystic carcinoma of parotid gland. Indian J Gastroenterol 2005 Jan-Feb;24(1):29-30.
  78. Qureshi SS, Shrikhande SV, Borges AM, Shukla PJ. Chest wall metastases from unknown primary hepatocellular carcinoma. J Postgrad Med. 2005 Jan-Feb;51(1):41-2.
  79. M. Kuenzli, S.V. Shrikhande, K. Adyanthaya, V. N. Shrikhande, M. W. Buechler, H. Friess. Pancreatic lesions in von Hippel-Lindau Syndrome: A case report of a 20 year old female. Surg Today 2004;34(7):626-9.
  80. Shailesh Shrikhande, Helmut Friess, Anand Nande, Kishor Adyanthaya, V. N. Shrikhande, M. W. Buechler. Novel technique of pancreatojejunal reconstruction following spontaneous closure of previous lateral pancreatojejunostomy. Int Surg 2004 Jan-Mar;89(1):46-50.
  81. Esposito I, Bergmann F, Penzel R, Di Mola FF, Shrikhande S, Buchler MW, Friess H, Otto HF. Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis. Virchows Arch 2004 Feb;444(2):119-26.
  82. Shailesh Shrikhande, Marcus Martignoni, Maithili Shrikhande, Helmut Friess, H. Ramesh, Markus Buechler. Inflammatory cell changes in alcoholic, idiopathic and tropical chronic pancreatitis. British Journal of Surgery 2003;90:1565-72.
  83. Shailesh Shrikhande, Palepu Jagannath. Current Options in diagnosis and management of Ampullary Carcinoma. Indian Journal of Surgery 2003;65:347-53.
  84. Helmut Friess, Zhaowen Zhu, Veronique Liard, Xin Shi, Shailesh V. Shrikhande, Li Wang, Klaus Lieb, Murray Korc, Carla Palma, Arthur Zimmermann, Jean Claude Reubi, Markus W. Büchler. Neurokinin 1 receptor (NK-1) and its potential effects on tumor growth in Human Pancreatic Cancer. Lab Invest 2003;83(5):731-42.
  85. Shailesh Shrikhande, Jörg Kleeff, Kishor Adyanthaya, Arthur Zimmermann, Vinayak Shrikhande. Management of Hepatobiliary Cystadenocarcinoma. Digestive Surgery 2003;20(1):60-3.
  86. Peter Büchler, Howard Reber, Manuela Büchler, Shailesh Shrikhande, Markus Büchler, Helmut Friess, Gregg Semenza, Oscar Hines. Hypoxia inducible factor-1 (HIF-1) regulates VEGF expression in pancreatic cancer. Pancreas 2003;26(1):56-64.
  87. Helmut Friess, Shailesh Shrikhande, Maithili Shrikhande, Marcus Martignoni, A. Kappeler, A. Zimmermann, H. Ramesh, Markus Buechler. Neural alterations in surgical stage chronic pancreatitis are independent of the underlying etiology. GUT 2002;50(5):682-6.
  88. Shailesh Shrikhande, Helmut Friess, Adrien Tempia, Jörg Kleeff, Arthur Zimmermann, Markus Borner, Markus W. Büchler. Bile duct infarction following intra-arterial hepatic chemotherapy mimicking multiple liver metastasis: Report of a case and review of the literature. Dig Dis Sci 2002;47:338-44.
  89. Prakash Patil, Niteen Tapuria, Shailesh Shrikhande, Anita Shah, Girish Muzumdar, Chaudhary. Stage I cervical cancer with missed early pregnancy. Bombay Hospital Journal 2002;44(1):109-110.
  90. Palepu Jagannath, Shailesh Shrikhande, Prashant Mullerpatan, Sujai Hegde, Rajeev Shah. Isolated Caudate Lobe Excision. Indian Journal of Gastroenterology 2002;21:113-114.
  91. Anand Nande, Shailesh V. Shrikhande, Vipulroy Rathod, Kishor Adyanthaya, Vinayak N. Shrikhande. Modified technique of Gasless Laparoscopic Cholecystectomy in a developing country: A 5-year experience. Digestive Surgery 2002;19(5):366-72.
  92. Helmut Friess, Shailesh Shrikhande, Erick Riesle, Mikiya Kashiwagi, Karl Baczako, Arthur Zimmermann, Waldemar Uhl, Markus Buechler. Phospholipase A2 isoforms in acute pancreatitis. Ann Surg 2001 Feb;233(2):204-12.
  93. Shailesh Shrikhande, Helmut Friess, Markus Buechler. Pseudocysts in Chronic Pancreatitis. Bombay Hospital Journal 2001;43(1):62-68.
  94. Shailesh Shrikhande, Helmut Friess, Fabio diMola, Adrien Tempia, Jose Conejo Garcia, Arthur Zimmermann, Markus Buechler. NK-1 receptor gene expression is related to pain in chronic pancreatitis. Pain 2001 Apr;91(3):209-17.
  95. Shailesh Shrikhande, Joerg Kleeff, Helmut Friess, Markus Buechler. Co-existent chronic pancreatitis and neuroendocrine tumor of the pancreas. Pancreatology 2001;1:117-122.
  96. Fumiaki Ozawa, Helmut Friess, Beat Kuenzli, Shailesh V. Shrikhande, Tiachi Otani, Masatoshi Makuuchi, Markus Buechler. Treatment of Pancreatic Cancer: The Role of Surgery. Dig Dis 2001;19(1):47-56.
  97. Prasad Agashe, Shailesh Shrikhande. Genetics of hereditary colorectal cancer for the practising surgeon. Bombay Hospital Journal 2001;43(3):364-370.
  98. Prasad Agashe, Shailesh Shrikhande. Genetics of breast cancer for the practising surgeon. Bombay Hospital Journal 2001;43(4):537-542.
  99. Prasad Agashe, Shailesh Shrikhande. Cancer genetics: Counseling, Psychological and Medicolegal issues. Bombay Hospital Journal 2001;43(3):374-379.
  100. Jörg Kleeff, Helmut Friess, Hans Peter Bode, Shailesh Shrikhande, Peter J. Bryant, Murray Korc and Markus W. Büchler. Altered Expression and Localization of the Tight Junction Protein ZO-1 in Primary and Metastatic Human Pancreatic Cancer. Pancreas 2001;23(3):259-265.
  101. Irene Esposito, Helmut Friess, Andreas Kappeler, Shailesh Shrikhande, Jörg Kleeff, Hariharan Ramesh, Arthur Zimmermann, Markus W. Büchler. Mast Cell Distribution and Activation in Chronic Pancreatitis. Human Pathology 2001;32:1174-83.
  102. Zhao Lu, Jorg Kleeff, Shrikhande, A. Zimmermann, M. Korc, H. Friess, M. W. Buechler. Expression of the multidrug resistance –1 (MDR-1) gene and prognosis in human pancreatic cancer. Pancreas 2000; 21(3):240-247.
  103. Shailesh Shrikhande, Helmut Friess, Claudia Issenegger, Marcus Martignoni, Huang Yong, Rodney Yeates, Jorg Kleeff, Markus Buechler. Fluconazole Penetrates into the Pancreas: Rationale for Antifungal Prophylaxis in Necrotizing Pancreatitis. Antimicrobial Agents and Chemotherapy 2000; 44(9):2569-2571.
  104. Fumiaki Ozawa, Y. Kondo, Shailesh Shrikhande, Helmut Friess, Markus Buechler. Duodenum Preserving Pancreatic Head Resection for Chronic Pancreatitis: Its Rationale and Results. J Hepatobiliary Pancreat Surg 2000; 7:456-465.
  105. Marcus E Martignoni, Helmut Friess, Florian Sell, Lars Ricken, Shailesh V Shrikhande, Christoph Kulli, Markus W Buechler. Enteral Nutrition delays gastric emptying in patients following Whipple`s resection. American Journal of Surgery 2000; 80:18-23.
  106. Shailesh Shrikhande, Prakash Patil. Management of Metastatic Mesenteric Granulosa cell tumor. Bombay Hospital Journal 2000; 42(4):633-34.
  107. Prakash Patil, Shailesh Shrikhande, Praful Desai. Multiple Primary Presentations of Squamous Cell Carcinoma associated with Palmoplantar Hyperkeratosis: Case Report and Review of the Literature. Bombay Hospital Journal 2000; 42(3):502-504.
  108. Shailesh Shrikhande, Helmut Friess, Markus W. Buechler. Duodenum Preserving Pancreatic Head Resection for Chronic Pancreatitis. Indian Journal of Surgery 1999; 61(5):291-296.
  109. Shailesh Shrikhande, Helmut Friess, Marcus Martignoni, Pascal Berberat, Markus Buechler. Chronic Pancreatitis: New Pathophysiological Aspects and Organ Preserving Surgery. Bombay Hospital Journal 1999; 41(4):720-730.

Recent Media Coverage & Updates

Media Coverage
November 12, 2023

A 10-step guide to reforming cancer care in India

Without systemic changes the disease could proliferate to epidemic levels over the next decade. With these, the country can become a beacon of low-cost, high-quality care for the Global South.…
Rajesh Bhatkar
Media Coverage
August 27, 2023

As gastrointestinal cancers spiral, doctors blame lifestyle

The number of patients registering for gastrointestinal (GI) cancers at Mumbai's Tata Memorial Hospital has increased by 200% between 2010 and 2022. This rise may be due to lifestyle changes…
Rajesh Bhatkar
Media Coverage
August 20, 2023

Tata Memorial Hospital’s new Parel building to have 500+ beds

Work on constructing a new 17-storey state-ofthe-art building for Tata Memorial Hospital (TMH) that will almost double its existing bed strength has recently started in the adjoining Haffkine Compound in…
Rajesh Bhatkar